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FORETELLING THE FUTURE OF PROGNOSTICATION: A HISTORICALLY 
INSPIRED DOMAIN-BASED APPROACH FOR THE ELDERLY 
John M. Thomas and Terri R. Fried.  Section of Geriatrics, Department of Internal 
Medicine, Yale University School of Medicine, New Haven, CT. 
Hypothesis:  1) Physicians’ decisions to discuss hospice as an option for terminally ill 
patients are based on a limited approach to prognostication that excludes many patients 
who may benefit from discussions.  2) Identifying broader domains of health most 
important for prognostication, as an alternative to calculating life expectancy or mortality 
risk, might encourage prognostication and improve physician-patient communication. 
Aims:  1) To examine the association between physicians’ prognostic assessments and 
their discussion with patients about hospice.  2) To identify the domains of health-related 
characteristics of older hospitalized patients and nursing home residents most strongly 
associated with short-term mortality. 
Methods:  Following an historical introduction on prognostication, we describe two 
empiric studies.  First, we performed secondary analyses of surveys administered to 215 
patients age ≥60 years with advanced cancer, chronic obstructive pulmonary disease, or 
heart failure that were performed at least every 4 months for up to 2 years, as well as 
surveys to their respective physicians at least every 6 months.  Then we performed a 
systematic review of prospective studies that evaluated the association between at least 
one health-related patient characteristic and mortality within one year among patients age 
≥65 years.  All studies published in English in MEDLINE, Scopus, or Web of Science 
before August 1, 2010 were eligible.   We categorized the characteristics into a series of 
domains.  Using the results of multivariable analyses, we ranked domains within each 
 
study according to strength of association with mortality, then calculated the overall 
relative strength of each domain as compared to other domains across studies. 
Results:  Apart from diagnosis of cancer, the factors most strongly associated with 
hospice discussion in our empiric analysis were physicians’ estimate of and certainty 
about patient life expectancy (P<0.001). That said, physicians did not anticipate the 
deaths of 40% of patients.  In the systematic review, we classified characteristics 
associated with mortality from forty-eight studies into seven domains:  cognitive 
function, disease diagnosis, laboratory values, nutrition, physical function, pressure sores, 
and shortness of breath.  The most important domains for prognostication were nutrition 
and shortness of breath among general nursing home residents; physical function and 
shortness of breath among nursing home residents with dementia; disease diagnosis, 
nutrition, and pressure sores among hospitalized patients for in-hospital mortality; and 
physical function and nutrition among hospitalized patients for mortality up to one year. 
Conclusions:  Clinicians’ discussion of hospice for patients with advanced illness relies 
largely on a highly unreliable prognostic approach that involves estimated life 
expectancy, and many clinicians whose patients might benefit from learning about 
hospice are not having these discussions.  Among a large number of health-related 
characteristics of older persons shown to be associated with short-term mortality, a few 
consistently important domains provide broad, easily measurable factors that may 
promote an approach to prognostication that simply alerts physicians to patients who are 
at increased risk for mortality, rather than aiming for certainty in life expectancy, thus 
encouraging physician-patient communication for elderly persons nearing the end of life. 
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“Life is short, the art long, 
 opportunity fleeting, 
 experience treacherous, 
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The purpose of this historical exercise, which will be followed by two empiric 
studies, is not so much to provide a comprehensive account of the thought and practice of 
prognostication throughout Western medicine, because that would require a great deal 
more discussion; but rather, to trace the evolution of a word – prognosis – and thus 
support the argument that this venerable and sacred practice of prognostication has lost 
over time its true appeal and meaning; for the field of medicine, if it truly seeks progress, 
must look to the past as it looks to the future.  
What is the reason for this need to approach medicine, and thus prognostication, 
with an awareness of historical practice?  Does medicine not forge ever onward in its 
pursuit of knowledge and its ability to heal?  The answer lies in the fact that medicine, 
ever-advancing scientifically, underwent a paradigm shift that directed attention towards 
individual diseases and away from diseased individuals, resulting in both tremendous 
advancements and harmful neglects.  In Ancient times and for long after, when the 
mechanisms of disease had not yet been worked out, an emphasis was placed on the 
broader manifestations of disease, such as signs and symptoms, for determining 
prognoses.  While this approach may seem oversimplified to the modern reader, it was 
the best that could be done at the time and served a valuable and cherished purpose when 
treatments were largely not available.  On the other hand, the practice of modern 
medicine, which understands the histopathological basis for disease, has placed an 
emphasis on disease diagnosis for determining prognoses.  This approach may, too, be 
oversimplified, especially for elderly patients with comorbid conditions and for whom 
8 
treatments often do more harm than good.  Although in place for decades, this recent 
paradigm emphasizing disease diagnosis has become increasingly problematic. 
Two Medical Traditions 
Although throughout Western history the practice of medicine has varied greatly, 
appreciating the larger theoretical structures that have informed the practice of medicine 
over time is essential for understanding the transformation that occurred in 
prognostication.  Indeed, an argument can be made for two largely distinct medical 
“traditions,” separated by a scientific revolution alluded to previously, that have operated 
under the same name of medicine but with decidedly different theoretical bases and 
emphases. 
The first thread of medical “tradition” can be traced from Classical Antiquity until 
approximately 1800, in which learned physicians fundamentally relied on the writings of 
their predecessors, recent or distant, in their understanding of health and disease.  
Scientific knowledge handed down from antiquity went for a long time unquestioned, and 
even as advances and discoveries were made that sometimes contradicted previous 
thought, the basic underpinnings of medicine remained the same.
1
  A principle example 
of this is the persistence of the theory of humors, from which the practice of bloodletting 
was derived. 
In the nineteenth century, discoveries were made that forever changed the face of 
medicine.
2
  The acceptance of germ theory brought with it fundamental insights into the 
mechanisms of disease.  Great strides followed, including developments in vaccination 
and antiseptic practices.  A glance at the past exposed glaring errors, and thus the former 
centuries-old “tradition” of medicine no longer retained its importance or centrality.  
9 
While occasional references to the writings of esteemed physicians of the past continued 
to be made, especially quotes attributed to Hippocrates, such references tended to serve 
as general “wisdom” in the art of medicine rather than having immediate authority.  The 
rapid advancements of science seemed to cast a shadow over the art of medicine, which, 
while still present, struggled to adapt to an ever-changing practice as developments 
exploded into the twentieth century and beyond. 
The Decline of Prognosis 
An article on prognostication in Lancet from 1934 reads:  “Of the three great 
branches of clinical science – diagnosis, prognosis, and treatment – prognosis is 
admittedly the most difficult.  It is also that about which least has been written and of 
which our knowledge is least systematized.” 
3
  This observation is typical of the second 
“tradition” of Western medicine, in which a precise understanding of the basis of disease, 
aided by technological progress, resulted in dramatic advancements in diagnostics and 
treatment options.  The practice of prognosis, on the other hand, did not enjoy the same 
excited attention.  For example, one can see the gradual disappearance of discussions 
about prognosis from medical textbooks in the twentieth century, whereas during the first 
“tradition” prognosis was often heralded as something to be cultivated.  Although in 
recent times accurate prognostication has become the target of increased scientific 
inquiry, attempts to encourage its clinical use have been unsuccessful, especially for 
elderly persons nearing the end of life.  A more thorough discussion of this problem will 
appear later. 
The explanation I would suggest for the decline in status of prognosis is threefold, 
although essentially a unified concept:  first, a transformed understanding of disease 
10 
directed attention away from individual patients and towards individual diseases, thus 
equating prognosis with diagnosis and destroying the tie between prognosis and broader 
patient characteristics; second, the rise in effective treatments for individual diseases 
further diminished the need to assess prognosis for individuals with these diseases; and 
third, prognostication has been perceived as characteristic of the first medical “tradition,” 
which was dismissed by modern science. 
Ultimately, in the face of an aging population, physicians would do well to realize 
that the interplay of comorbid conditions and the often-mixed effects of treatments 
necessitate the use of signs and symptoms once again, in addition to diagnostics, for the 
purpose of prognostication.  In other words, a careful consideration of both individual 
diseases and diseased individuals is required for the restoration of prognosis to the same 
status as diagnosis and treatment.    
In the subsections that follow, prognostication as it has been described in various 
historical periods will be discussed, with occasional comments about concurrent 
developments in medicine to provide context. 
Classical Antiquity 
 
The body of works attributed to Hippocrates contains several treatises on 
prognostication, and among these is On Prognostics, which contains an excellent 
overview of the importance of this art in the Ancient practice of medicine:  “It appears to 
me a most excellent thing for the physician to cultivate prognosis; for by foreseeing and 
foretelling, in the presence of the sick, the present, the past, and the future, and explaining 
the omissions which patients have been guilty of, he will be the more readily believed to 
be acquainted with the circumstances of the sick.”
4
  Notably, the definition of prognosis 
11 
rendered here is broader than the modern accepted usage.  Rather than being limited to 
predicting the likely course and outcome of illness, it also involves relating to the patient 
current and prior aspects of that patient’s illness.  The reason for this becomes clear in his 
subsequent discussion:  that the purpose of prognostication is as much about gaining the 
trust and confidence of patients as it is about effecting a cure.  “Thus a man will be the 
more esteemed to be a good physician, for he will be the better able to treat those aright 
who can be saved, from having long anticipated everything; and by seeing and 
announcing beforehand those who will live and those who will die, he will thus escape 
censure.”  The ability to prognosticate, then, was an important means by which 
physicians could distinguish themselves, demonstrate their worth, and avoid criticism. 
To the modern reader, the Hippocratic use of the word prognosis might be 
perceived as heavily contingent upon the concept of diagnosis.  After all, arriving at the 
correct diagnosis in modern times generally affords an explanation of the patient’s past 
and present state of health, as well as a prediction for the future.  It must be remembered, 
however, that the understanding of disease in Classical Antiquity was based not on an 
understanding of “agents of disease” or cellular pathology, but rather on a long-accepted 
theory of four humors, in which an imbalance of one or more humors would result in a 
disease state.  Thus, prognostication in the time of Hippocrates was rather contingent 
upon observing the signs and symptoms of illness, and placing them in the context of 
attributes of the patient, such as age and robustness, to arrive at insights about the past, 
present, and future course of illness. 
 Though Hippocrates probably enjoys the greatest renown today among Ancient 
practitioners of medicine, the central figure in the development of the first medical 
12 
“tradition” was probably Galen, who lived nearly five centuries after the time of 
Hippocrates.  Galen’s influence was so great that subsequent generations accepted his 
writings without question.  His writings not only documented his own experimental 
findings, which were considerable in volume, but summarized and synthesized the 
writing of his predecessors, not the least of which was Hippocrates.  Because of the 
tremendous regard for his work in the centuries that followed, Galen was in effect the 
“sieve” through which previously known medicine passed onto subsequent generations.
1
 
Likewise, with regards to prognostication, his treatise Of Critical Days 
importantly discusses in great detail certain theories that not only indicate some of the 
practices of the time but would exert a lasting influence.
5
  In this treatise, he discusses the 
concept of crisis, which is the crucial point at which a sick patient either dies or is 
restored to health.  He also describes a method for calculating critical days, or the days in 
which a crisis is most likely to occur.  This method relies entirely upon the principles of 
astrological medicine, in which the sun and moon were believed to influence the course 
of illness, for good or bad, in predictable intervals in accordance with their movements 
with respect to the Earth.  Galen’s description of astrological technique as a 
prognostication tool would have influences well into medieval times. 
From Medieval to Modern Europe 
A great deal of medical texts from Classical Antiquity would have been lost in the 
centuries that followed, had they not been preserved as part of the Arab-Islamic medical 
tradition.
1
  Indeed, until the late eleventh century, very little changed in the practice of 
medicine in Europe.  It was not until the translation of medical texts from Arabic and 
13 
Greek, augmented by the rise of universities, that the tradition begun by Hippocrates and 
extended by Galen and Arab medicine was introduced into the Latin-speaking world.   
One result of this sharing of texts is the Summary on Crisis and the Critical Days, 
a medical work on prognostication written by an anonymous author in the late thirteenth 
century.
6
  It effectively marks the introduction into Medieval Europe of the complex and 
highly sophisticated astrology described by Galen, as it heavily relies on Of Critical Days 
for its material and frequently cites it.  The Summary on Crisis and the Critical Days 
achieved wide popularity among university physicians in the Latin-speaking world over 
the course of three centuries. 
 In the sixteenth and seventeenth centuries, a pronounced renewal of interest in 
Galen and Greek medicine occurred in Europe.  Such an interest can be observed in the 
English text, “Prognostication drawen out of the books of Ipocras, Avicen, and other 
notable auctours of physycke,” printed at least as early as 1550 by Robert Wyer.
7
  
Noticeably, the use of the word prognosis in this text is limited to predicting “whether in 
peryl of death be in them or not, the pleasure of almyghty God reservyd.”  An example of 
its approach to prognostication can be found in the discussion on sweat, here spelled 
“swete”:  “Where the swete is, there is the [sickness].  The swete which cometh now and 
then is nought.  Swete with [weakness] of the pulse, is nought.  Note swete in the [head], 
in the continual fever onely is nought.  And if it be colde, it betokeneth death.”  It is 
unclear for whom this particular publication was intended, but given that in early modern 
Europe learned medicine was often popularized in the vernacular and used by educated 
lay people as well as trained physicians (an English statute in the mid-sixteenth century 
14 
even legalized the unlearned practice of medicine), it is possible that Wyer published the 
text for a less discerning population. 
 Among university-trained physicians, probably the most outstanding work on 
prognostication in the sixteenth and seventeenth centuries was called The presages of life 
and death in diseases: in seven books, written by Prosper Alpini.
8
  This text relies heavily 
on the Hippocratic and Galenic writings for their descriptions of the methods of 
prognostication, achieving a comprehensive synthesis.  The author claims to have 
confirmed these methods “not only by the sentiments and opinions of the ancient 
physicians, but also by a long course of attentive observation and experience.”  In fact, 
nearly one hundred pages are devoted to a discussion of critical days and crises, including 
a description of the astrological origin of the concept of critical days.  Alpini’s use of the 
term prognostication, unlike that of Wyer, is consistent with the Hippocratic definition 
found in On Prognostics.   
At the same time that a renewed interest in Classical Antiquity occurred in the 
sixteenth and seventeenth centuries, which comprised part of the early modern era in 
Europe, various challenges against conservatism developed and ran alongside it.
1
  The 
problems of plague and syphilis, which seemed to be “contagious,” forced flexibility into 
the Galenic approach that did not allow for “agents” of disease to be communicated from 
one person to another.  New discoveries were made in anatomy and physiology, 
including quite influentially the concept of circulation of the blood.  Finally, the 
introduction and acceptance of modern philosophy promoted a “new science,” which 
reduced biological processes to mere mechanical events, removing the mysterious, 
cosmological component allowed for by Aristotelian philosophy.  Overall, it was 
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increasingly acceptable, even fashionable, to reject Galen’s teachings.  In contrast to 
Galen, however, the reputation of Hippocrates was relatively unscathed.  While Galen 
was accused of going beyond experience and thus dogmatically espousing erroneous 
teachings, Hippocrates was seen as guided by experience and personifying great bedside 
observation. 
The resultant transformation of medical ideology that well over a century of “new 
science” incited may be seen in a treatise by James Harvey written in 1706, called, 
Praesagium Medicum, or, the Prognostick Signs of Acute Diseases.
9
  In the text, signs 
and symptoms are discussed in exquisite detail with respect to their further 
characterization, likely cause, and the likelihood of recovery.  Although descriptions of 
the mechanisms of disease are often reminiscent of humoral theory, Harvey decidedly 
discounts the approach of Classical Antiquity in his discussion of crises and critical days, 
proclaiming the progress of medicine in its improved knowledge of prognostication:  
“Everybody knows how religiously critical days were observed by the Ancient 
physicians.  But, later ages have wiped off the dust of antiquity, discovered its infirmities, 
and enriched the art of physick with closer observations and discoveries…”  He 
specifically discounts astrological medicine, stating that crises and critical days were “not 
fixed to a certain and determinate number, the moon’s motion, or that of any other 
constellation…”  His understanding of crises and critical days, rather, was based upon the 
inner workings of the body without regard for the influence of the cosmos. 
Nevertheless, Harvey’s use of the word prognosis remains consistent with the 
Hippocratic definition.  In addition to stating the likely outcome associated with 
particular signs and symptoms, he characterizes them in detail and discusses their causes.  
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In fact, the minority of the discussion is devoted to predicting the future course of illness.  
Instead, Harvey emphasizes the importance of not being too specific in prognostication:  
“A prudent and wary physician therefore will be moderate and ambiguous in his 
promises, and reserved in his prognostics, unless founded upon certain and infallible 
signs.”   
It would seem that Harvey’s approach to prognostication is the result of a keen 
awareness of the Hippocratic writings combined with a heightened scrutiny and 
skepticism towards certain concepts passed down from Classical Antiquity.  His 
reluctance to offer predictions about the future outcome of illness is perhaps a 
characteristic of the “new science” that rejected the orthodox explanations of crises and 
critical days and acknowledged an uncertainty about the timing of recovery or death.  
Nonetheless, he appreciated the scope of prognostication as defined by Hippocrates and 
discussed fully the aspects of prognostication where he felt the science had advanced. 
This advancement was limited, however.  Despite the accumulation of greater knowledge 
during the sixteenth and seventeenth centuries, only rarely did effective new treatments 
develop.  Instead, the focus of scientific progress was on anatomy, physiology, and the 
mechanisms of disease. 
Although the eighteenth century still saw no radical transformation in medical 
therapeutics, the Enlightenment movement strengthened physicians’ ambitions to further 
medical “progress” through scientific findings, with the ultimate aim to gain better 
control over nature.
1
  Certain strategies, including quantification and classification, 
allowed for greater objectivity and a more systematic approach to understanding health 
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and disease.  The future loomed large as the science of medicine progressed, although 
major breakthroughs were still lacking. 
Characteristics of the eighteenth century approach to medicine can be found in the 
treatise, Observations on the prognostic in acute diseases, written by Charles Le Roy and 
published in English in 1782.
10
  For instance, there is an attempt to achieve greater 
precision in prognostication:  “In a work of this sort, only by much the smaller number of 
prognostics, can be as certainties: the rest will vary in their degrees of probability.  It has, 
therefore, been my aim, to adapt my expressions to the degree of probability, which 
seemed to belong to each prognostic.”  While the treatise is a tribute to Hippocrates, 
making frequent reference to him, Le Roy emphasizes the need to verify the observations 
handed down from Antiquity:  “I have very seldom spoken of any prognostics, that I have 
not seen confirmed in my own practice…”   
In the organization of the treatise, and in the use of the word prognosis, Le Roy 
takes very much the same approach found in the Hippocratic writings.  An important 
underlying assumption is that particular signs and symptoms, even if they may be caused 
by a variety of different diseases, still portend the same prognostic significance and can 
be addressed in the same way regardless of the underlying disease.   
The Nineteenth Century 
 In the aftermath of the political revolutions of the late eighteenth century, Western 
society was becoming increasingly fluid, with a growing emphasis on the rights of 
individuals.
2
  This was the milieu in which profound change and upheaval occurred in 
medicine.  On the one hand were physicians who looked to the future and saw “tradition” 
as something to be avoided; on the other hand were physicians who held fast to 
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“tradition,” even all the way back to Hippocrates, and were suspicious of so-called 
scientific “advancements.”  Some saw the time-tested method of acquiring knowledge 
through clinical observation at the bedside as being threatened by the growth of 
experimental science.  This tension makes Pasteur’s achievements as a non-physician 
scientist all the more remarkable, as he helped define a revolution in medicine through 
his advocacy of germ theory and his developments in the fields of microbiology and 
immunology.  Although new scientific discoveries often met with resistance and only 
gradually won general acceptance, the underpinnings of health and disease were 
profoundly changing.  
 In The Sequels of Disease, written in 1896, Dyce Duckworth offers some insights 
into the dramatic changes occurring in medicine and their impact on the practice of 
prognostication:  “I venture to state that…in spite of the extraordinary advances made in 
all branches of the sciences…the attention of physicians has been somewhat inadequately 
directed to the subject of prognosis in diseases.”
11
  In fact, Duckworth was unaware of 
any other work in the nineteenth century purely dedicated to the subject of prognosis.  He 
asserted that so much attention in medicine was being devoted to acquiring accurate 
factual knowledge that few physicians had taken the time to synthesize and reflect upon 
the information so that broader observations could be made.  
 In lamenting the endangered status of prognostication, Duckworth observes a key 
distinction:  “It was in connection with a humoral pathology that prognosis made the 
greatest progress, and achieved its highest triumphs.  The doctrines of solidism on the 
other hand have uniformly proved inimical to the study of prognosis.”  It is unclear 
exactly what he means by this, because he does not go on to explain why “solidism,” the 
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doctrine that cells and tissues are the focus of disease, is not conducive to 
prognostication. 
 One can observe, however, that The Sequels of Disease is organized in its 
discussion of prognosis according to disease rather than by sign and symptom.  Thus, the 
discussion becomes quite different:  there are no assumptions about particular signs and 
symptoms having the same prognostic significance regardless of disease, as was the case 
in Le Roy’s work and all the works on prognostication prior to it back to the time of 
Hippocrates.  This new approach reflects the revolution that had occurred in the 
understanding of pathogens as agents of disease.  The science of prognostication, then, 
was to have a different foundation, and the writings on prognostication prior to the 
revolution, including the Hippocratic works, would seem less relevant than ever. 
The Twentieth Century 
The tumultuous era that encapsulated the two World Wars was characterized by a 
steady growth in medicine.
2
  Hospitals grew in size, specialization increased, medical 
technologies such as x-ray machines and electrocardiographs came into widespread use, 
and penicillin was developed and successfully aided Allied troops in the later years of 
World War II.  After the war, the field of medicine developed at an unprecedented rate, 
with immense increases in research funding and extensive drug development.  The strong 
awareness of the past that had characterized the practice of medicine throughout the 
entire “first” tradition had essentially vanished, as physicians no longer looked to the 
writings of Hippocrates.  An ever-increasing body of knowledge and technological 
capability was seen as affirmation that progress was being achieved.  By the 1970s, 
however, the public increasingly began to question medical authority, as healthcare 
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expenses kept escalating and occasional mishaps like the thalidomide tragedy occurred.  
The surge of new treatment options began to slow by 1980, and it became clear that cures 
for cancer and other diseases like Parkinson’s would be slow in development.  Infectious 
disease, once thought to be nearly a thing of the past, began to reassert itself with drug-
resistance; the identification of HIV/AIDs in particular extinguished hopes of eliminating 
infection.  Despite increasing treatment capabilities and financial investments in 
medicine, the ironic phenomenon of “doing better and feeling worse” arose in the 
developed West. 
Evidence for the decline in attention to prognostication over the course of the 
twentieth century can be seen quite simply in the evolution of medical textbooks.  
Nicholas Christakis demonstrated this through a content analysis of a series of editions of 
The Principles and Practice of Medicine, a textbook authored originally by William 
Osler.
12
  From 1892 to 1988, the percentage of chapter lengths devoted to prognosis 
decreased steadily from about 10% to 0%.  He observed that as the discussion of 
treatment on a topic increased, the discussion of prognosis inversely decreased, 
presumably because as disease became more treatable the likely outcome became more 
routine.  For highly treatable diseases, then, the need for prognostic considerations was 
diminished. 
In the same article, Christakis argued that the status of prognostication also 
suffered in the context of an evolving concept of disease during the “Oslerian era.”  
Whereas prior to the time of Osler disease was considered to be highly personal and 
greatly influenced by the “constitution” of the patient, in the “Oslerian era” a shift 
occurred towards focusing on the agents of disease.  In this way, two very dissimilar 
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patients infected by the same pathogen could be seen as having the “same” illness, with 
characteristics of the individuals relegated to the background. 
Perhaps a third explanation for the decline of the status of prognostication at the 
turn of the century was its perception as “unscientific.”  In The Evolution of Modern 
Medicine, for example, Osler discusses medical knowledge and practice as it developed 
from the time of the Classical Antiquity to the present, and the only mention of 
prognostication in the entire volume is in the context of the astrological practices of 
medieval physicians.
13
  Although Osler indeed devoted portions of his medical textbook, 
The Principles and Practice of Medicine, to discussions of prognosis, a close inspection 
of the final edition written solely by him reveals high variability in whether prognosis is 
discussed for any given disease.
14
  To cite a few examples, the discussion of prognosis 
for lobar pneumonia is extensive, for typhus fever it is limited to an estimated mortality 
rate, and for Hodgkin’s disease it is absent. 
 Despite the general decline in attention paid to prognostication over the course of 
the twentieth century, the topic never disappeared entirely from academic discussion, and 
even some attempts to foster the general practice of prognostication occurred.  The start 
of the twentieth century seems to have been, at least in part, a time for retrospection.  An 
editorial from the Journal of the American Medical Association (JAMA) in 1901 assures 
readers that prognostication “is not entirely a natural gift, or a mysterious power granted 
to the few, but that it is just as much the result of reading, study, observation at the 
bedside and in the deadhouse, and of logical reasoning as is a scientific diagnosis or 
rational therapy.”
15
  One physician, in 1904, referring to the legacy of Hippocrates, 
writes, “The older prognosis, far from being negligible, is really of fundamental 
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importance.  It gives the accumulated experience of ages that, untrammeled by detail, 
carefully noted broad and elementary features of disease.”
16
 
In the decades that followed, discussions about prognostication seem to have 
shifted away from historical contextualization towards improving the science.  From 
1934 to 1936, an entire series of articles dedicated to disease-specific discussions on 
prognostication were published in Lancet.
3
  In 1953, a physician describes 
prognostication as a “stepchild in medical advance,” and insists that “we can do better 




 That same year, the first prognostic index was developed for patients admitted to 
the hospital with a myocardial infarction.
18
  While the original purpose was to develop a 
way to quantify patient severity of illness for the purpose of comparing the equivalency 
of the experimental and control arms of an experiment, this “Pathologic Index Rating” 
was found to be closely related to mortality rate.  Following this initial paper, countless 
other prognostic indices were developed covering a multitude of patient populations, with 
newer indices sometimes offering advantages over older ones.  An editorial in the New 
England Journal of Medicine in 1971, on the calculation of prognosis, states, “Properly 
derived, a prognostic index can guide the physician in his discussion with the family.  It 




Clearly, as evidenced by the exponential development of prognostic indices from 
the 1950’s onward, a promising approach had arrived, one that would ensure the 
advancement of the science of prognostication.  Would this development finally restore 
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prognosis to the same status in medicine as diagnosis and treatment?  The likely answer 
could be found in an in-depth analysis of a landmark study. 
The SUPPORT Experiment 
The largest-scale attempt to improve prognostication through a research 
intervention was the Study to Understand Prognoses and Preferences for Outcomes and 
Risks of Treatment (SUPPORT), conducted in the mid-1990s.
20
  The basis for the 
intervention was the initial observational finding that discussions and decision making 
between physicians and patients regarding end-of-life care uncommonly happened 
substantially before death.  Only half of physicians knew when their patients preferred 
not to have cardiopulmonary resuscitation (CPR), and half of do not resuscitate orders 
were written within 2 days of death.  Furthermore, patients were found to commonly 
receive aggressive treatment near the end of life:  half of patients in their final 
hospitalization spent at least 8 days in the intensive care unit (ICU), on a mechanical 
ventilator, or in a comatose state.  Finally, pain control was largely inadequate, given that 
half of able-to-communicate patients reported moderate to severe pain most of the time in 
their final days. 
Based upon the largely unfavorable data on the care patients received approaching 
the end of life, an intervention was designed to address these deficiencies by providing 
physicians with accurate prognostic information regarding individual patients, including 
the likelihood of mortality each day up to 6 months and predictions of future functional 
ability, as well as providing physicians with patient preferences for end-of-life care.  A 
prognostic model was derived from a population of seriously ill patients who had one of 
the following diseases:  acute respiratory failure, multiple system organ failure with 
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sepsis or malignancy, coma, chronic obstructive pulmonary disease, congestive heart 
failure, cirrhosis, colon cancer, and lung cancer.
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  The steepness of the prediction curve 
used for any given patient was based on the class of disease, and the placement of the 
curve with respect to the x- and y- axes was based on severity of disease, as calculated 
from 14 variables easily obtained from hospital records.  Thus, the model generated a 
point estimate of the likelihood of surviving to each day shown on the graph, along with 
error bars to show variability in these estimates.  A unique prediction could be made for a 
given patient on every reporting day.  This model was shown to be about as accurate in 
its estimates as attending physicians were, but combining the estimate of the model with 
that of the attending resulted in a much improved estimate over either alone.   
The intervention aspect of SUPPORT utilized this model in an attempt to improve 
the parameters of patient care described above through the provision of timely and 
accurate prognostic information to physicians and patients, the elicitation of patient 
preferences for end-of-life care, and the facilitation of communication and planning by a 
skilled nurse.  Despite all these efforts, the experiment was a failure in that it did not 
improve any of the target outcomes although the study was sufficiently powered to detect 
small differences.  The authors were at a loss to explain the reasons for this.  Many 
hypotheses were generated about potential limitations of the study design, but the 
ultimate consensus was that none of these limitations could account for the utter lack of 
change in any measure.  Questions were asked about whether physicians and patients 
even agreed that these measures of end-of-life care were in need of improvement.  
Perhaps there was nothing wrong with the design of the trial itself, it was suggested, but 
rather more systemic changes were required before real changes could occur. 
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Clearly, the failure of SUPPORT was of such epic proportions that one could 
reasonably suggest the trial’s inability to win the hearts of the physicians involved.  The 
task of relaying the prognostic information itself was not a problem, given that reports 
were automatically provided to physicians and that nurses were hired to discuss prognosis 
with patients.  However, the provision of this information, even in an environment that 
encouraged discussions, did nothing to change the approach of physicians. 
One is tempted to ask about the attitudes of physicians towards the provision of 
this meticulously calculated but highly statistical prognostic information.  Did it actually 
change their perceptions about the patient’s life expectancy?  After all, estimates of the 
model were only as good as the physician’s best guess.  The additional consideration of 
combining estimates of the model with physicians’ estimates to result in a more accurate 
prediction at first seems encouraging, but it offers a mixed message to physicians that 
makes it unclear whether the model can even be trusted, and if not trusted, exactly how 
much the prediction should be altered.  Given that discussions were suggested to be 
explicitly based on the calculated prognostic information provided, how would 
physicians explain to patients such alterations in a way that inspires confidence? 
Physicians’ reservations about offering prognostic estimates to patients were later 
characterized in a national survey of internists, in which they described prognostication 
as being “stressful” and “difficult,” and believed that patients expect too much certainty 
and may lose confidence in them if an incorrect prediction is made.
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  Perhaps most 
revealingly, 90% of physicians believed they should avoid being too specific in their 
prognostic estimates, which calls into question the very approach of the SUPPORT trial.  
Thus, evidence suggests that physicians were probably less than enthusiastic about being 
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offered calculated prognostic estimates and had misgivings about discussing them with 
patients. 
In addition to questioning the approach of offering calculated prognostic estimates 
to physicians and patients in SUPPORT, one might also wonder about the lack of 
improvement in communication between physicians and patients.  The proportion of 
patients reporting a discussion about CPR was no different from that of the control group, 
even though over 40% of patients for whom CPR was not discussed reported that they 
wished to discuss it.  Nor was the proportion of patients reporting a discussion about 
prognosis with their physician different from that of the control group, although again 
over 40% of patients not reporting this discussion said they wished to have it.  Granted, 
physician reporting of these discussions was not obtained, allowing for the possibility 
that patients forgot about conversations or did not recognize them as such; however, such 
an influence would be expected to affect both the experimental and control groups 
equally, thus maintaining whatever differences may have resulted from the intervention.  
Therefore, it seems that while many patients wanted to have these discussions, their 
physicians were either unaware of it or unwilling to honor the wishes of their patients.  
Clearly the problem of lack of communication was rooted in more than simply the lack of 
readily available prognostic estimates. 
The SUPPORT trial is the strongest scientific demonstration available that the 
meticulous provision of prognostic calculations that are as accurate as can be reasonably 
achieved does not improve communication between physicians and patients, and has no 
effect on decisions about the aggressiveness of care at the end of life.  Supported by 
evidence from physician survey, there are strong reasons to assert that such calculations 
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cannot achieve enough accuracy to make physicians comfortable with these sensitive 
discussions of prognosis for patients approaching the end of life.   The provision of 
detailed estimates that are no better than physicians’ estimates and that could perhaps be 
improved by physicians’ estimates introduces a complex psychological game for having 
end-of-life discussions that is challenging at best. 
The Legacy of Prognostic Models for Seriously Ill Patients 
 Two years after the publication of the primary results of SUPPORT, Joanne Lynn 
and others published a paper in a low impact journal with data on the limited ability of 
prognostic models to identify patients near the end of life.
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  Two different models were 
analyzed for the relationship between median estimates of survival and actual time to 
death:  the SUPPORT model, whose population is described above, and the APACHE III 
model, whose population consisted entirely of ICU patients. 
 In the SUPPORT model, the median predicted chance of survival for 2 months 
was 0.51 (0.31-0.66) 1 week before death, with substantial variations according to disease 
diagnosis.  The APACHE model was slightly less optimistic for the same parameter (0.45 
median predicted chance of survival). 
 The overall conclusion was that in order to make plans about care and properly 
support patients and families, discussions need to happen while the patient still has a 
decent chance of surviving the current episode of illness, and that designations of 
“terminally ill” for the sake of public policy would be necessarily arbitrary and 
controversial. 
Into the Twenty-First Century:  Prognostic Indices for Clinical Practice? 
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 The future of prognostication in both clinical research and clinical practice has 
been unclear for well over a decade.  Overall, it would seem that the lessons from the 
SUPPORT trial were either ill-acknowledged or quickly forgotten:  the failure of 
SUPPORT was followed by a surge of new prognostic models, many of which attempted 
to identify patients at risk for mortality within 1 year or less.  Typically, the information 
provided in indices generated from these models was less extensive than the information 
provided to physicians and patients in SUPPORT, and prognostication based on these 
indices required calculation on the part of the physician. 
An editorial on the use of prognostic indices in clinical practice appeared in 
JAMA in 2001.
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  The authors observed that while prognostic indices are widely 
developed in clinical research, their use in clinical practice is surprisingly rare.  Various 
challenges in the development and use of prognostic indices were discussed, including 
the greater difficulty in generating life expectancy estimates as opposed to mortality risk 
estimates, the difficulty of memorizing the elements of a risk index and calculating a 
score, the lack of data comparing model estimates against clinician estimates, the lack of 
explicit advice for applying estimates to clinical decisions, the “fatalism” implicit when 
factors included in prognostic indices are unmodifiable, and the difficulty patients 
sometimes have in comprehending probabilities.  Overall, the authors declared that “the 
strongest argument for prognostic indices is that they facilitate professional 
communication,” although such communication of probabilities among physicians is 
unlikely to dominate the medical field in the near future. 
An evaluation of selected mortality prediction tools, published in 2011,
25
 
demonstrated that most tools have only modest accuracy, with large variation in 
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discriminating performance when compared in different clinical studies.  Even tools that 
have found wide clinical use, such as APACHE II and MELD score, had inconsistent 
accuracy when tested in different studies.  It was suggested that existing literature may 
even be biased toward exaggerating the accuracy of these tools since studies with 
unimpressive results are less likely to be reported or published.  Additionally, most 
mortality prediction tools lack demonstrated clinical utility.  
Prognostication for the Elderly 
 There has been a recent surge of interest in evaluating prognostic models designed 
for elderly populations.  The concurring opinion is that the use of such models in clinical 
practice is premature.  For instance, one systematic review identified a total of 193 
models consisting of participants 50 years and older, and found that only 34% of these 
models were externally validated, and only 2% were validated in more than two studies.
26
  
Another systematic review identified 16 prognostic indices generated from patient 
populations whose average age was 60 years or older and that predicted absolute risk of 
mortality from 6 months to 5 years.
27
  It was found that none of the indices had excellent 
discrimination (C statistic of ≥0.90), and only 2 indices were externally validated by 
researchers other than those who developed the index.  The authors concluded that while 
prognostic indices are potentially useful for influencing clinical decisions that rely on 
estimated life expectancy, their use cannot be recommended before further studies 
demonstrate their accuracy in diverse populations and their ability to modify clinical 
outcomes. 
 An editorial accompanying the latter systematic review discussed the importance 
of prognostication for making fully informed clinical decisions.
28
  It argued that elderly 
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populations, who are more likely to have competing comorbidities and decreased life 
expectancy, can especially benefit from the use of prognostication.  For instance, 
estimates of life expectancy can be directly applied to clinical guidelines as outlined in 
the systematic review; some examples of decisions related to considerably diminished 
life expectancy, in addition to the hospice eligibility guidelines, include discontinuation 
of statins with life expectancy of ≤6 months, and non-operative management of 
asymptomatic abdominal aortic aneurysms with life expectancy of <1-2 years.  The 
editorial also discussed a number of problems with current prognostic indices.  In 
addition to being premature for clinical use, most indices are designed to generate 
mortality risk for a specific time interval rather than estimates of life expectancy; the 
latter approach would be more clinically applicable.  Also, there is the problem of the 
lack of evidence that prognostic indices can improve patient outcomes.  Despite these 
limitations, the editorial argued that clinicians ought to be trained currently in how to use 
prognostic tools. 
The Future of Prognostication for the Elderly 
  Despite the greater accumulation of prognostic indices for elderly persons over 
the past two decades, a substantial amount of evidence calls into serious question whether 
such methods will ever achieve enough accuracy to have more than limited usefulness in 
the clinical setting.  Even if one or more indices eventually manages to gain acceptance 
by clinical research standards, based on accuracy in diverse populations and improvement 
of clinical outcomes in randomized controlled trials, it has yet to be shown that doctors 
will be willing to use these inherently imperfect tools in prognostication for individual 
patients.  One might expect that if these prognostic indices are ever applied to specific 
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clinical decisions, the higher the stakes of the decision, the less likely doctors will be to 
use them.  For example, they would be especially problematic for identifying elderly 
persons nearing the end of life for the purpose of discontinuing curative treatments. 
 What is the underlying problem with prognostic indices?  Do they not at least 
consider more than individual diseases in generating prognostic estimates?  Perhaps the 
problem lies in the quantification itself, which not only may give a false impression of 
accuracy, but also represents a population-based average rather than truly representing an 
individual. 
 The future of prognostication for the elderly lies in realizing that certainty is 
unachievable, especially for persons with comorbid illness and for whom treatments are 
often problematic.  Instead of aiming for an unachievable goal, clinical researchers might 
seek to use the substantial amount of available scientific evidence in a way that considers 
broader manifestations of disease, such as signs and symptoms, in addition to disease 
diagnosis, while deemphasizing quantitative prognostic estimates.  This approach draws 
upon historical perspectives on prognostication, while simultaneously maintaining the 
scientific rigor that has long characterized clinical research.
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STATEMENT OF PURPOSE 
Hypotheses:   
1) Physicians’ decisions to discuss hospice as an option for terminally ill patients 
are based on a limited approach to prognostication that excludes many patients who may 
benefit from discussions.   
2) Identifying broader domains of health most important for prognostication, as an 
alternative to calculating life expectancy or mortality risk, might encourage 
prognostication and improve physician-patient communication. 
Aims:   
1) To examine the association between physicians’ prognostic assessments and 
their discussion with patients about hospice.  
 2) To identify the domains of health-related characteristics of older hospitalized 
patients and nursing home residents most strongly associated with short-term mortality. 
33 
PART I: Prospective Cohort Study 
While attention to prognostication in medicine has declined over the past century, 
so that it no longer enjoys a status alongside diagnosis and treatment as it once did, it has 
regained some consideration in recent years with the development of an ever-increasing 
number of prognostic models.  That being said, the concept of prognosis has narrowed 
significantly since the first medical “tradition,” now referring almost exclusively to 
quantitative estimates of life expectancy or mortality rate.  Perhaps the most classic 
example of the modern use of prognosis is the Medicare Hospice Benefit requirement of 
a life expectancy of ≤6 months for hospice enrollment,
29
 although notably alterations to 
the eligibility criteria have been suggested in an attempt to more reliably identify persons 
who would be appropriate for hospice.
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  Proposed characteristics to identify such 
persons include functional status, quality of life, and burden of symptoms rather than 
estimates of life expectancy. 
Hospice referral is simply one issue among many that physicians face as they 
attempt to guide patients who are approaching the end of life.  Another issue is informing 
patients about their potential care options, including hospice services.  In fact, one 
identified barrier to hospice use is physicians’ lack of discussion about hospice with the 
patient and family. 
31,32
  This observation has been supported by retrospective studies, in 
which caregivers, recalling their conversations with physicians, often deny any 
communication about hospice or alternative treatment options.
33-35
  Such discussions 
about treatment options may be vital for guiding patients in their transition from being 
gravely ill to dying.
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 no prospective study has examined determinants of discussions about 
hospice, regardless of whether the patient ultimately utilizes hospice services.  Thus, it is 
unclear what role prognostication has in physicians’ decisions to discuss the option of 
hospice with seriously ill patients. 
The aim of this prospective cohort study
40
 was to examine patient-and physician-
related factors associated with reported hospice discussions, with a particular emphasis 
on the relationship between physicians’ prognostic estimates and hospice discussions. 
 
METHODS 
 The data set used for this first component of the study was created by Dr. Fried 
and detailed elsewhere.
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  A description of participants and data collection contributing to 
the data set appears below. 
Participants 
Participants of the study were ≥60 years of age and had a primary diagnosis of 
cancer, chronic pulmonary obstructive disease (COPD), or heart failure (HF).  Persons 
screened for the study were being cared for as inpatients in a Veterans Affairs hospital, a 
university teaching hospital, and a community hospital; as outpatients in two Veterans 
Affairs hospitals; and as outpatients in four oncology, three pulmonology, and six 
cardiology practices in the greater New Haven area.  Each of the participating hospitals’ 
human investigations committees approved the study protocol.  All patients gave 
informed consent. 
Sequential medical charts were reviewed for the primary eligibility criterion of 
advanced illness, as defined by the National Hospice Guidelines
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 A second eligibility criterion was the need for assistance with 
one or more instrumental activities of daily living (IADLs)
45
; this was determined by 
telephone screening and chosen to improve the identification of persons with advanced 
illness,
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  Patients were required to be full-time residents of Connecticut and have no 
cognitive impairment as evaluated by a test of executive functioning
47
 and the Short 
Portable Mental Status Questionnaire.
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  Screening and enrollment were stratified 
according to diagnosis in order to achieve equal numbers of participants with a diagnosis 
of cancer, COPD, and HF. 
Of the 548 persons identified by medical chart review, 30 were not contacted 
because their physicians declined permission, 24 died prior to telephone screening, 19 
declined screening, and 6 could not be reached.  Of the persons screened by telephone, 
108 were excluded because they were independent in all IADLs, 77 because they were 
cognitively impaired, and 6 because they were residents of a state other than Connecticut.  
Of the 279 eligible persons, 51 declined participation and 2 died before enrollment.  The 
final sample consisted of a total of 226 persons, with 82% participation of eligible 
persons.  Participants and non-participants did not differ statistically according to gender, 
age, or Charlson comorbidity index score,
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 with P<0.05 as cutoff.  Eight percent of 
eligible persons with HF declined participation, compared to 19% with cancer and 25% 
with COPD (P=0.02).  Of the 226 participants, eight (4%) withdrew after the initial 
interview, 26 (12%) died before a follow-up interview, and three (1%) were not able to 
complete follow-up interviews.  Of the 124 participants still living one year after 
initiation of the study, 98 (79%) agreed to participate for the second year. 
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Patient participants identified the physician primarily responsible for the 
management of their primary diagnosis.  Of 105 physicians identified, 96 (91%) 
consented to participate and completed interviews for a total of 215 patients.  Patient 
participants whose physician participated in the study did not differ from patients whose 
physician did not participate, when compared according to age, gender, ethnicity, 
education, and income.  None of the physicians of patients with cancer declined to 
participate, compared to 15% of physicians for patients with HF and 2% of physicians for 
patients with COPD and (P<0.001).  The database used for this study included only the 
215 patients whose physicians participated. 
Data Collection 
Patients were interviewed in their homes every four months for up to two years 
and immediately following any decline in status, defined by the presence of one of the 
following:  need for assistance with an additional activity of daily living,
50
 hospitalization 
for ≥7 days or resulting in discharge to a nursing home or rehabilitation center, or 
enrollment in a hospice program.  Physicians filled out a survey by mail every six 
months.  For this study, we used the last completed physician survey for each respective 
patient.  To ensure correspondence of information, we used the patient interview that 
most closely preceded the physician survey. 
The outcome variable was whether the physician discussed hospice.  We 
determined hospice discussions by physicians’ answer to the question of whether they 
had discussed hospice with the patient and/or family.  If physicians reported not 
discussing hospice, they were asked to choose from a list of reasons why.  We 
determined receipt of hospice services by patient self-report, which was supplemented by 
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surrogate report if the patient was too ill to participate in an interview or died during the 
study.  
Descriptive and analytic variables extracted from patient interviews included 
measures of health, sociodemographic, and psychosocial status.  We dichotomized 
ordinal variables at clinically relevant cut points.  Health status variables included self-
rated health (“excellent,” “very good,” “good,” “fair,” or “poor”) and an assessment of 
symptoms, using the Edmonton symptom assessment scale.
51
  Sociodemographic 
variables included gender, age, education, ethnicity, marital status, living arrangement, 
and sufficiency of monthly income.
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  Psychosocial variables included perceived 
prognosis (patients were asked, “If you had to take a guess, how long do you think that 
you might have to live?,” with responses of “<1 month,” “1-6 months,” “7-12 months,” 
“13-23 months,” “2-5 years,” “6-10 years,” or “>10 years”), overall quality of life (“best 
possible,” “good,” “fair,” “poor,” or “worst possible”),
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 willingness to undergo major or 
minor therapies if they would restore the patient’s current state of health (major therapies 
were described as “being in the intensive care unit, receiving surgery, or having a 
breathing machine” and requiring hospitalization of “at least a month,” while minor 
therapies were described as “[receiving] intravenous antibiotics and oxygen,” and 
hospitalization of “a few days to a week”), and awareness of alternatives to 
hospitalization (patients were asked a series of questions: “If your illness should become 
worse than it is now, what, if anything, has your doctor told you about how you could be 
treated?,” then, “If you were sick enough that you potentially would need the hospital, do 
you think that you would have any choices other than being hospitalized?,” and if so, 
“What is/are the choices?,” followed by, “If you wanted to stay out of the hospital, do 
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you know of any services that could help you?,” and if so, “What are they?”).  Each 
interview contained the health status and psychosocial variables described above. 
Physician surveys included the following descriptive and analytic variables:  best 
prediction of the patient’s life expectancy (<1 month, 1-6 months, 7-12 months, 13-23 
months, 2-5 years, 6-10 years, or more than 10 years), and level of certainty regarding it 
(99%, >90% certain, 50-90%, 10-49%, <10%, or <1% certain); whether they had told 
the patient that he or she could die as a result of the disease; and whether they had 
discussed with the patient his or her life expectancy. 
Statistical Analysis 
Statistical analyses were performed by Mr. O’Leary.  Patient-reported and 
physician-reported variables were described using frequencies and proportions, with the 
variables expressed in total and stratified according to diagnosis.  Bivariate analysis was 
used to examine the association between these variables and physician report of hospice 
discussion, by means of the chi-square test or, in the case of small cell sizes, the Fisher 
exact test.  Variables associated in bivariate analysis with hospice discussion (P<0.15) 
were included in a logistic regression model (gender was entered into the model a priori).  
Given that physicians’ estimates of life expectancy and discussions of hospice were 
strongly associated, we examined the accuracy of physicians’ estimates by calculating the 




Patient-related characteristics are shown in Table 1.  Although 71% of patients 
reported their health to be fair or poor, only 12% reported their quality of life to be poor.  
Patients’ estimates of their life expectancy were considerably more optimistic than their 
physicians’ estimates.  While 10% of patients believed they had ≤1 year to live, 41% of 
physicians estimated their patients’ life expectancy to be ≤1 year.  Of the patients whose 
physicians made this estimate, the largest proportion had a diagnosis of cancer (76%), as 
compared to COPD (22%) or HF (19%).  Only 14% cited hospice as an alternative to 
hospitalization, and of these patients, 52% had physicians who reported discussing 
hospice, suggesting that few patients knew about hospice outside of a conversation with 
their physician. 
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Age, %     
60-69 35 42 37 25 
70-79 45 46 43 47 
80+ 20 13 20 28 
     
Education ≤ 12 years, % 68 63 75 67 
     
Female, % 42 43 49 30 
     
White†, % 91 92 92 86 
     
Lives alone, % 25 16 27 33 
     
Health perception fair to poor‡, % 71 68 71 75 
     
Quality of life poor to worst possible§, % 12 13 13 11 
     
Selected moderate to severe symptoms, %     
Pain‖  29 38 19 29 
Decreased activity level§ 63 56 73 60 
Depression§ 13 11 15 13 
Shortness of breath‖  42 20 71 32 
     
Unwilling to undergo therapies for return to 
current health, % 
    
Major therapies‡ 11 9 14 9 
Minor therapies§ 2 3 1 4 
     
Physicians’ estimate of patient life 
expectancy ≤ 1 year, % 
41 76 22 19 
     
Physician reported informing patient of life 
expectancy, % 
30 62 10 14 
     




10 10 13 7 
*COPD = Chronic obstructive pulmonary disease; HF = heart failure   




Hospice Discussion and Associated Factors 
Overall, physicians reported discussing hospice with 22% of patients.  The 
reasons most frequently cited for not discussing hospice were “not terminally ill” (50%) 
and “prognosis too uncertain” (37%).  Patient-centered reasons were less frequently cited, 
such as “would take away patient’s hope” (10%) and “patient wants life-sustaining 
therapies” (9%) (Table 2). 
 









Physician discussed hospice with patient 
or family†, % 
22 46 10 7 
     
Reasons for not discussing hospice†, %     
Not terminally ill 50 32 66 55 
Prognosis too uncertain 37 29 48 34 
Patient would not handle this discussion 
well 
5 0 10 4 
Patient wants life-sustaining therapies 9 15 6 5 
Would take away patient’s hope 10 8 19 2 
Services would not benefit patient 9 11 5 13 
*COPD = Chronic obstructive pulmonary disease; HF = heart failure 
†N=214 
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Selected patient- and physician-related characteristics and their association with 
hospice discussion are shown in Table 3.  Physicians of patients with cancer were more 
likely to report a discussion (46%) than physicians of patients with COPD (10%) or with 
HF (7%) (P < .001).  Among physicians who estimated their patients’ life expectancy to 
be ≤1 year, 49% reported discussing hospice, compared to only 4% when they estimated 
a longer life expectancy (P < .001). Within the subset of physicians who estimated their 
patients’ life expectancy to be ≤1 year, hospice discussion was reported much more 
frequently by physicians who were >90% certain about their estimate than by physicians 
who were less certain (93% versus 40%, P < .001).  Physicians were more likely to report 
discussing hospice for patients who self-reported poorer quality of life, moderate to 
severe pain, a perceived life expectancy of ≤1 year, an unwillingness to undergo minor 
therapies for a return to current health, and that their physician informed them of their life 
expectancy.  However, 40%-69% of physicians whose patients had these characteristics 
did not report a hospice discussion.  There was no association between hospice discussion 
and patients’ self-rated health or unwillingness to undergo major therapies for a return to 
current health. 
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No Discussion of 
Hospice (n=167) 
P-value 
Diagnosis, %    
Cancer 46 54  
Chronic Obstructive Pulmonary Disease 10 90  
Heart Failure 7 93 <.001 
    
Pain*, %    
Moderate to severe 31 69  
None to mild 19 81 .057 
    
Activity level reduction†, %    
Moderate to severe 26 74  
None to mild 17 83 .113 
    
Quality of life†, %    
Poor or worst possible 42 58  
Best possible, good, or fair 20 80 .011 
    
Patient unwilling to undergo minor therapies for 
return to current health†, % 
   
Yes 60 40  
No 22 78 .043 
    
Patients’ self-perceived life expectancy‡, %    
≤1 year 41 59  
>1 year 20 80 .028 
    
Physicians’ estimate of patient life expectancy, 
% 
   
≤1 year 49 51  
>1 year 4 96 <.001 
    
Physicians’ level of certainty about patient life 
expectancy when estimate is ≤ 1 year, % 
   
>90% 93 7  
≤90% 40 60 <.001 
    
Physician reported informing patient of life 
expectancy, % 
   
Yes 57 43  
No 7 93 <.001 
*N=213; †N=212; ‡N=210 
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In multivariable analysis, physicians’ estimate of patient life expectancy ≤1 year 
was the strongest determinant of hospice discussion (odds ratio (OR) = 13, 95% 
confidence interval (CI) = 4.3–39) (Table 4). A cancer diagnosis was independently 
associated with hospice discussion; other factors associated with hospice discussion in 
bivariate analysis did not retain their significance.  One variable, “physician informed 
patient of life expectancy,” was not entered into the model because of its high correlation 
with “physician-estimated life expectancy ≤1 year” (Pearson correlation coefficient, 
>0.3).  Another variable, “physician certainty about life expectancy,” was not entered into 
the model because it was measured only among the sub-group of physicians who 
estimated their patients’ life expectancy to be ≤1 year. 
 
Table 4.  Multivariable model for characteristics associated with hospice discussion 
Variable 
Odds ratio (95% 
confidence interval) 
Cancer diagnosis 3.4 (1.3-8.9) 
  
Male  1.9 (0.8-4.5) 
  
Moderate to severe pain 1.0 (0.4-2.5) 
  




Fair/poor self-rated quality of life 2.1 (0.6-7.6) 
  
Patient self-perceived life 
expectancy ≤ 1 year 
1.7 (0.5-5.8) 
  
Physicians’ estimate of patient life 
expectancy ≤ 1 year 
13 (4.3-39) 
  
Patient unwilling to undergo minor 




Accuracy of Physician Prognosis 
A total of 56% of the patients died during the course of the study, including 77% 
of patients with cancer, 42% of patients with COPD, and 47% of patients with HF.  Of 
patients who died, 40% had physicians who estimated that their life expectancy was >1 
year, within six months before patient death.  Stratified according to patient diagnosis, 
physician overestimate of prognosis applied to 11% of patients with cancer and 68% of 
patients with COPD or HF. 
 
DISCUSSION 
In this study consisting of older adults with advanced cancer, COPD, and HF, 
physicians reported discussing hospice for nearly one-half of patients with cancer but 
only a small fraction of patients with COPD or HF.  Several characteristics suggesting 
that patients might benefit from hospice were associated with a greater likelihood of 
discussion, including moderate to severe symptoms, unwillingness to undergo minor 
medical interventions, and poorer quality of life, but nonetheless, a considerable number 
of patients with these characteristics did not have the discussion.  Other characteristics of 
a similar nature, such as poorer self-rated health and unwillingness to undergo major 
medical interventions, were not associated with hospice discussion.  The strongest 
determinant of hospice discussion was physicians’ estimate of and level of certainty 
about patient life expectancy.  Nonetheless, physicians were unable to identify as having 
a poor prognosis a considerable percentage of patients who subsequently died within six 
months. 
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These findings are consistent with a prior study in which physicians reported that 
the difficulty of prognostication was the foremost barrier to the physician offering 
hospice.
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  However, in contrast to the prior study, physicians in this study did not cite 
patient readiness to handle the discussion and preferences for treatment as major barriers 
to discussion.  One conceivable explanation for this discrepancy is that in the current 
study physicians were asked about specific patients at specific times rather than general 
barriers to discussion.  Nonetheless, given evidence from previous research suggesting a 
substantial lack of communication between physicians and patients about end-of-life 
preferences,
20
 it is possible that most physicians do not assess whether patients are ready 
to handle these discussions or willing to undergo major or minor therapies.  Given the 
results of this study, it would seem that patients are often not informed about alternatives 
to standard therapy because physicians’ discussion of hospice is determined largely by 
their assessment of and level of certainty about patient life expectancy. 
The close relationship shown in this study between level of prognostic certainty 
and hospice discussion appears to imply that more accurate prognostication would 
enhance physician-patient communication at the end of life.  However, substantial 
research evidence indicates the limited value of a quantitative approach to 
prognostication for patients approaching the end of life.  First, clinical prediction criteria 
based on National Hospice Organization guidelines for patients with COPD and HF have 
been demonstrated ineffective in recognizing patients with a life expectancy of six 
months or less.
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  Second, as previously discussed, providing state-of-the-art prognostic 





Although communication and care at the end of life will be unlikely to improve 
with greater prognostic accuracy, nonetheless, the results of this study confirm that they 
may be improved by adequately addressing the problem of prognostication.  Given the 
relatively narrow approach to prognosis taken in the past century, the practice of 
prognostication is unlikely to improve significantly without a dramatically new approach 
that is based on sound science but less statistically oriented.  One example of this, as 
stated above, is the suggestion for altering the Medicare Hospice Benefit requirements to 
include criteria such as functional status, symptom burden, and quality of life.
30
  This 
alternative approach would potentially include the many patients in this study whose state 
of health or preferences suggest that they may have benefited from hospice services, but 
who did not benefit from discussions with their physicians about hospice.  However, 
more research is needed to further support this approach, which may not gain easy 
acceptance among researchers or policymakers who have primarily focused for decades 
on a quantitative approach. 
One of the limitations of this study is that descriptions of the nature of discussions 
about hospice were not obtained, including whether physicians simply provided 
information about services or also made a recommendation; nonetheless, given the large 
proportion of patients in this study who utilized hospice following the discussion, it 
would seem that discussions were mainly characterized by the latter.  A second limitation 
is that information was obtained by self-report, with no confirmation as to whether the 
discussions reported by physicians took place.  Physicians, who completed surveys at six-
month intervals, may have been asked to recall discussions that took place months prior.  
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Additionally, desirability bias may have influenced the responses.  It is also possible that 
physicians were more likely to have discussions as a result of participating in the study. 
In this study, physicians’ decisions to discuss hospice for older persons with 
advanced illness were influenced mainly by an approach to prognostication that focuses 
on estimates of life expectancy and the predictability of disease course.  It is important 
for physicians to have such discussions with terminally ill patients so that patients can 
understand their options and make informed decisions about their care at the end of life.  
Since prognostication for patients with non-cancer diagnoses has particular limitations, 
hospice discussions occur primarily for patients with cancer near the end of life.  Many 
persons who might benefit from hospice, as suggested by their health status and treatment 
preferences, are not having these discussions with their physicians.  Based on prior 
evidence, more accurate prognostication tools are unlikely to improve communication 
between physicians and patients at the end of life, thus necessitating a different approach 
to prognostication that is less numerical and more conceptual in orientation. 
The next section will further explore the possibilities for a more conceptual 
approach to prognostication for elderly persons nearing the end of life, by means of a 
thorough literature review and subsequent synthesis of data. 
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PART II:  Systematic Review 
Despite a recent increased interest in prognostication, the practice of it remains 
rare because of a limited conceptual understanding and approach.  As a primary example, 
prognostic models, which are popular in clinical research but not clinical practice, 
erroneously strive to achieve a level of certainty about life expectancy that can be applied 
to individuals.  The technical problems with prognostic models are numerous:  their 
overall accuracy is only modest,
25,55
, they have not been externally validated in most 
cases,
26
 and they contain varying combinations of specific factors that may not be readily 
measured in all clinical settings.  Furthermore, physicians have reported that they prefer 
to avoid specific estimates when discussing prognosis with patients,
56,57
 which is 
consistent with evidence from the SUPPORT trial, in which the availability of more 
accurate prognostic information did not improve communication between physicians and 
patients.
20
  Finally, although physicians generally agree that discussions about end-of-life 
issues occur too late,
40,58
 there is no consensus about what clinical markers might prompt 
discussions
58,59
 and prognostic models of mortality do not provide this information. 
Alternatively, a broader understanding of the domains of health most strongly 
associated with mortality might allow for assessments aimed simply at identifying 
patients with increased mortality risk, so that a deficit in one of the most important 
domains would prompt re-evaluation of the approach to care.  This alternative may be 
more acceptable to physicians than calculations of absolute mortality risk, and may be 
more readily used in time-limited clinical settings.  It also serves to broaden the approach 
to prognostication, which has been severely restricted in recent decades to a quantitative 
estimate of life expectancy. 
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 A systematic review has the potential to take a comprehensive compilation of all 
known factors associated with mortality and to identify larger patterns of association 
across studies.  This information may then be used to identify broader categories of 
health-related characteristics associated with mortality.  No such review now exists in the 
literature, the closest being one review
60
 that examined factors associated with a number 
of outcomes in older hospitalized patients, but their goal was to provide a system for 
measuring hospital case mix.  They evaluated length of stay, discharge destination, and 
readmission rates in addition to mortality, and they combined in-hospital mortality and 
mortality up to 2 years following admission as outcomes in their analyses. 
The goals of this systematic review were as follows:  1) to identify health-related 
characteristics of older hospitalized patients and nursing home residents associated with 
short-term mortality (1 year or less), 2) to classify these characteristics into domains of 




Data Sources and Searches 
Mr. Thomas performed an electronic literature search of all English articles 
published in MEDLINE (1948-), Scopus (1960-), or Web of Science (1899-) before 
August 1, 2010 to identify prospective cohort studies on factors associated with short-
term mortality in elderly hospitalized patients and nursing home residents.  The 
MEDLINE search used a combination of “filters,” consisting of MeSH terms, 
subheadings, text words, and multi-purpose terms, designed to maximize sensitivity and 
specificity for this topic.  The following filters were used:  prognosis studies, mortality, 
predictors, age, hospitalized patients, and nursing home residents.  Modified forms of the 
same filters were used for the Scopus and Web of Science searches (Table 5). 
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Table 5.  Literature search strategies for MEDLINE, Scopus, and Web of Science 
 
MEDLINE Search Strategy 
 
Prognosis studies filter 
1.  incidence/ 
2.  exp mortality/ 
3.  Follow-Up Studies/ 
4.  mortality.fs. 
5.  prognos:.tw. 
6.  predict:.tw. 
7.  course.tw. 
8.  outcome:.tw. 
9.  1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
 
Predictors filter 
1.  risk:.mp.  
2.  assess:.mp.   
3.  predict:.mp.  
4.  factor:.mp.   
5.  screen:.mp.   
6.  probability:.mp. 
7.  exp risk/ 
8.  1 or 2 or 3 or 4 or 5 or 6 or 7 
 
Mortality filter 
1.  exp mortality/ 
2.  exp death/ 
3.  exp survival analysis/ 
4.  Life Expectancy/ 
5.  mortality.fs. 
6.  death.mp. 
7.  survival.mp. 
8.  mortality.mp. 
9.  die:.mp. 








Prognosis study filter and Mortality filter and Predictors filter and Age filter = 
Combo filter 
Combo filter was then combined with the hospitalized patients filter and with the nursing 
home residents filter in separate searches. 
 
Hospitalized patients filter 
1.  hospital:.ti. and (elder: or old: or geriatric:).mp 
2.  (elder: adj2 hospitali#ed).mp 
3.  (old: adj2 hospitali#ed).mp  
4.  (geriatric: adj2 ward:).mp.  
5.  (geriatric: adj2 unit:).mp.  
6.  intensive care.ti. and (elder: or old: or geriatric:).mp.  
7.  inpatient:.ti. and (elder: or old: or geriatric:).mp.  
8.  geriatric: hospital:).mp.  
9.  ICU.ti. and (elder: or old: or geriatric:).mp.  
10.  intermediate care.ti. and (elder: or old: or geriatric:).mp.    
11.  (ward or wards).ti. and (elder: or old: or geriatric:).mp.  
12.  ((acute: adj2 hospital:) and (elder: or old: or geriatric:)).mp.  




Table 5 (continued).  Literature search strategies for MEDLINE, Scopus, and Web 
of Science 
 
Nursing home residents filter 
1.  exp Residential Facilities/  
2.  Long-Term Care/  
3.  Institutionalization/  
4.  nursing home:.ti.  
5.  long-term care.ti.  
6.  extended care.ti.  
7.  1 or 2 or 3 or 4 or 5 or 6 
 
Scopus and Web of Science Search Strategy 
 
Prognosis studies filter 
mortality OR “follow up” OR outcome 
OR outcomes OR prognosis OR 
prognoses 




mortality OR death OR “life 
expectancy” 
OR survival OR “survival analysis” OR 
“survival analyses” OR die* 
Predictors filter 
risk OR risks OR screen* OR factor OR 
factors OR predict OR predicts OR 
predictor OR predictors 
 
Age filter 
elder OR elders OR elderly OR old OR 
older OR geriatric OR geriatrics
 
Prognosis study filter and Mortality filter and Predictors filter and Age filter = 
Combo filter 
Combo filter was then combined with the hospitalized patients filter and with the nursing 
home residents filter in separate searches. 
 
Nursing home residents filter 
“Nursing home” OR “nursing homes” OR “long term care” OR “extended care” OR 
“assisted living” OR Institutionali* 
 
Hospitalized patients filter 





A total of 7,644 articles were identified.  Of these, 5,393 were excluded by Mr. 
Thomas through title review, and the remaining 2,251 were reviewed in abstract form by 
Mr. Thomas and Dr. Cooney independently.  The 367 articles appearing to meet inclusion 
criteria, as presented below, based on review of the abstract alone were then retrieved and 
examined in full text.  Mr. Thomas and Dr. Fried reviewed the articles to determine 
whether they met inclusion criteria, and consensus was achieved, resulting in a total of 45 
articles included in this study.  To ensure completeness, the reference lists of the 45 
included articles were also reviewed by Mr. Thomas (by title at least, and if necessary, by 
abstract and full text), resulting in three additional articles.  In the same way, all articles 
published in Journal of the American Geriatrics Society from 2001 to 2010 were 
reviewed by Mr. Thomas, but no additional articles fulfilling inclusion criteria were 
identified (Figure 1). 
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Figure 1.  Summary of literature search and selection. 
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The final inclusion list contained 48 articles.  These articles were separated into 
the following categories based on patient population and follow-up period:  general 
nursing home residents, nursing home residents with advanced dementia, hospitalized 




Studies were included if their participants were hospitalized patients, long-stay 
nursing home residents, or nursing home residents with advanced dementia only, 
regardless of length of stay.  Long-stay was defined as residing in the nursing home for at 
least 3 months, and was specified to avoid cohorts containing patients receiving short-
term rehabilitation or other forms of subacute care.  We only included studies of persons 
age 65 years or older, or, if age range was not provided, studies with a population average 
age of ≥80 years.  We only included studies with a prospective cohort design, including 
studies that use chart or record review in a prospective fashion; studies that examine at 
least one health-related characteristic, meaning a characteristic inherent to the patient and 
not involving elements of health care treatment, medical devices, or living location; 
studies that measure mortality within a follow-up period of one year or less; and studies 
that contain at least bivariate analysis.  The criterion of a follow-up period of one year or 
less was chosen based on a cursory review of the literature in which a considerable 
number of studies on mortality specified a follow-up period of one year. 
 We did not include studies that excluded patients possessing characteristics 
potentially associated with mortality.  Specifically, we did not include studies of nursing 
home residents that excluded terminally ill persons, those receiving palliative care, or 
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those with specific illnesses, medications, or nutritional requirements; and we did not 
include studies of hospitalized patients that excluded nursing home residents, the 
terminally ill, patients receiving palliative care, those with specific illnesses or 
abnormalities, those who died in the hospital, or those living outside a prescribed 
geographical area. 
Data Extraction and Quality Assessment 
 
 We first sought to identify all markers for short-term mortality, regardless of 
whether they have independent association with mortality, because of their potential 
clinical usefulness even if they are subject to confounding.  Thus, from all studies 
fulfilling inclusion criteria, Mr. Thomas generated a list of health-related characteristics 
associated with short-term mortality in bivariate analysis (p<0.05) and organized them 
according to the categories of patient populations described above. 
 For the purpose of quality assessment, we modeled a set of six criteria after 
recommendations specific to prognosis studies in systematic reviews
61
 and applied them 
to the 48 articles meeting the inclusion criteria.  Twenty-four articles were determined to 
be of high quality, in that they fulfill all our criteria (Table 6). 
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Table 6.  Criteria used for assessing quality of articles that met inclusion criteria. 
 
Study population:  For patients who could not be interviewed, we required that the self-
reported data be sought from proxies. 
Attrition:  We required that loss to follow-up be no greater than 20%. 
Prognostic factors:  The reliability of data collection was considered for the following 
variables: dementia, delirium, malnutrition or malnourishment, and depression.  For these 
variables, clinical assessment rather than medical chart review was required. 
Confounders:  Because a determination of independent association was not required for 
this review, we did not include criteria related to confounders. 
Statistical analysis:  We required that the number of outcomes be at least ten times the 
number of variables in the model. 
Study design:  For studies that utilized secondary analysis of previously collected data, 
we assessed whether the original study was an observational cohort study or a 
randomized controlled trial.  Because randomized controlled trials may not include 
representative populations,
62
 we considered only studies derived from observational 
cohort studies to fulfill the quality criterion. 
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Data Synthesis and Analysis 
In order to organize the health-related characteristics associated with mortality 
and allow for broader, more meaningful comparisons, all three investigators (Mr. 
Thomas, Dr. Fried, and Dr. Cooney) reached consensus in grouping these characteristics 
into larger aspects of patient health, or domains.  Demographic information was not 
placed in a domain or included in subsequent analyses because the purpose of the review 
was to focus on health-related factors. 
The heterogeneity of study populations, independent variables measured, and 
statistical methods precluded combining results in a meta-analysis.  Therefore, Mr. 
Thomas and Dr. Fried developed methods of summarizing the strength of association of 
the different characteristics and domains with mortality across studies, based on the 
following:  1) the frequency, across individual studies, with which particular health-
related characteristics and domains were associated with mortality in bivariate and 
multivariable analysis; and 2) the relative ranking, within individual studies, of the 
strength of association with mortality for each domain of health-related characteristics. 
 Some single studies contained more than one cohort, and some pairs of studies 
contained identical cohorts.  For the data extraction step (performed by Mr. Thomas), we 
included such instances of repetition to ensure completeness in identifying all 
characteristics associated with mortality.  In the analysis steps (performed by Mr. 
Thomas), we excluded repetitive data as follows:  when studies consisted of both 
development and validation cohorts, data from the validation cohort was preferentially 
used, unless analyses were available only for the development cohort; and when studies 
were found to contain identical or overlapping populations, a single study was chosen 
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from among them on a case-by-case basis (Table 8). 
Individual characteristics were included in the first step of analysis if they were 
measured in more than one article category or in more than one study within a given 
category.  For every article that evaluated a given characteristic, we noted whether an 
association was found in bivariate analysis, and if assessed, in multivariable analysis.  
Then we calculated frequencies by dividing the number of times a characteristic was 
associated with mortality by the total number of times assessed for both bivariate and 
multivariable analysis.  Finally, we combined the frequencies for all characteristics 
within each domain to produce an overall calculation of the frequency with which a 
domain was associated with mortality out of the total number of times assessed in 
bivariate and multivariable analysis. 
In order to accomplish the second step, which summarized across studies the 
relative strength of association of a given domain compared to the other domains, we 
developed and executed a method of calculation based on multivariable analysis data.  To 
achieve this comparison, articles containing multivariable analysis were selected, and 
hazard ratios or odds ratios from these multivariable models were used to rank 
statistically significant (p<0.05) health-related characteristics from highest to lowest 
association within each study.  Health-related characteristics were then linked with their 
respective domains, and a ranking of the relative importance of domains for each article 
was generated.  If more than one factor was associated with a single domain, the domain 
was assigned to the strongest factor.  Finally, domains that were investigated but did not 
attain significance in multivariable analysis were placed at the bottom of the ranking list 
and set equal to each other. 
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The ranking of domains within each study was then compared across studies to 
generate an overall ranking of the relative importance of each domain.  Specifically, the 
number of instances a given domain outranked any other domain was divided by the total 
number of instances in which that domain was ranked against any other domain; this 
frequency was then multiplied by 100% to achieve a head-to-head ranking percentage 
(see Table 7 for an example).  These percentages, which we will refer to as measures of 
“relative strength,” were then compared to assign importance to domains.  This analysis 
was also performed for the subset of articles assessed to be of high quality. 
 
Table 7.  Example of head-to-head domain analysis to determine the relative 
strength of association with mortality for each domain compared to other domains. 
 

















  0:3 0:3 0:2 0:0 0:2 0/10 = 0% 
disease 
diagnosis 
3:0   2:1 0:2 2:0 0:2 7/12 = 58% 
physical 
function 
3:0 1:2   1:1 2:0 1:1 8/12 = 75% 
nutrition 2:0 2:0 1:1   2:0 1:1 8/10 = 80% 
pressure 
sores 
0:0 0:2 0:2 0:2   0:2 0/8 = 0% 
shortness 
of breath 
2:0 2:0 1:1 1:1 2:0   8/10 = 80% 
Each ratio in the white boxes above indicates a head-to-head comparison between two domains. To achieve 
an overall head-to-head ranking percentage for each domain, the number of instances a given domain 
outranked any other domain was divided by the total number of instances in which that domain was ranked 
against any other domain; this frequency was then multiplied by 100%. 
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Since not all domains were examined in all articles containing multivariable 
analysis, there was greater evidence supporting the “relative strength” of some domains 
as compared to others.  To our knowledge, no criteria exist for evaluating this variation in 
the amount of evidence for domains.  Hence, Mr. Thomas and Dr. Fried devised criteria 
that consider both quality and quantity of evidence, and made note of each domain that 
did not fulfill at least one of the following in its respective article category:  examined in 
at least 2 high quality articles, examined in at least 1 high quality article with a 




Our literature search identified 48 articles
63-110
 published before August 2010 that 
met the inclusion criteria (Table 8).  Nine studies involved general nursing home 
residents, two studies involved nursing home residents with advanced dementia, 24 
studies involved hospitalized patients with in-hospital mortality, and 17 studies involved 
hospitalized patients with mortality up to one year. 
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Table 8.  Studies on health-related characteristics associated with short-term 
mortality in the elderly 
 
General nursing home residents     
Reference Year Country Sample size Follow-up Quality Domains 
Barca et al.
63 2010 Norway 902 1 year + 3 
Flacker et al.
64
* 1998 USA 780 1 year  5 
Flacker et al.
65
† 2003 USA 15,068 1 year + 5 
Grabowski et al.
66 2005 USA 2,782 1 year + 1 
Kiely et al.
67
* 2000 USA 778 1 year  5 
Kiely et al.
68
† 2002 USA 33,188 1 year + 5 
Mooradian et al.
69 1991 USA 129 4 months + 1 
Perls et al.
70 1993 USA 1,951 6 months + 2 
Tsai et al.
71 2008 Taiwan 308 1 year + 1 
*†These pairs of studies used the same population for their respective analyses; the Kiely articles separated 
analyses by gender and were chosen for exclusion from analysis in this review. 
 
Nursing home residents with advanced dementia 
Reference Year Country Sample size Follow-up Quality Domains 
Mitchell et al.
72 2004 USA 4,631 6 months + 4 
Mitchell et al.




Table 8 (continued).  Studies on health-related characteristics associated with short-
term mortality in the elderly 
 
Hospitalized patients:  in-hospital mortality    
Reference Year Country Sample size Follow-up Quality Domains 
Abizanda et al.
91 2007 Spain 356 in-hospital + 1 
Agarwal et al.
92 1988 USA 80 in-hospital  3 
Alarcon et al.
74 1999 Spain 353 in-hospital  2 
Bienia et al.
93 1982 USA 59 in-hospital + 1 
Covinsky et al.
77 1997 USA 823 in-hospital  2 
Eeles et al.
80 2010 UK 278 in-hospital  1 
Gazzotti et al.
94  2000 Belgium 175 in-hospital + 5 
Incalzi et al.
95 1992 Italy 308 in-hospital + 4 
Incalzi et al.
96
* 1996 Italy 302 in-hospital  4 
Incalzi et al.
97
* 1997 Italy 370 in-hospital  5 
Iwata et al.
98 2006 Japan 1638 in-hospital + 2 
Jonsson et al.
99 2008 Iceland 749 in-hospital  3 
Marengoni et al.
100
† 2003 Italy 923 in-hospital  5 
Marengoni et al.
101
† 2008 Italy 596 in-hospital  5 
Narain et al.
85 1988 USA 396 in-hospital + 2 
O'Keeffe et al.
102 1997 Ireland 225 in-hospital + 1 
Pompei et al.
103 1994 USA 323 in-hospital  1 
Ponzetto et al.
104 2003 Italy 987 in-hospital  5 
Sampson et al.
105 2009 UK 617 in-hospital + 3 
Sonnenblick et al.
106 2007 Israel 779 in-hospital + 4 
Stratton et al.
107 2006 UK 150 in-hospital + 1 
Terzian et al.
108 1994 USA 4,123 in-hospital + 2 
Zafrir et al.
109 2010 Israel 333 in-hospital + 6 
Zekry et al.
110 2010 Switzerland 444 in-hospital  1 
*†These pairs of studies appear to have used the same study population for their respective analyses; Incalzi 
et al. 1997 was chosen for analysis because it evaluated a greater number of domains, and Marengoni et al. 
2003 was chosen because it more thoroughly evaluated physical functional measures. 
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Table 8 (continued).  Studies on health-related characteristics associated with short-
term mortality in the elderly 
 
Hospitalized patients:  mortality up to one year 
Reference Year Country Sample size Follow-up Quality Domains 
Alarcon et al.
74 1999 Spain 353 6 months  3 
Boyd et al.
75
* 2008 USA 2,279 1 year  1 
Buurman et al.
76 2008 Netherlands 463 3 months + 5 
Covinsky et al.
77 1997 USA 823 1 year  2 
Desai et al.
78
† 2002 USA 524 1 year  4 
Drame et al.
79 2008 France 1,306 6 weeks + 5 
Eeles et al.
80 2010 UK 278 1 year + 1 
Flodin et al.
81 2000 Sweden 552 1 year  3 
Gonzalez et al.
82 2009 Chile 542 3 months  3 
Inouye et al.
83 2003 USA 1,246 1 year  5 
Laurila et al.
84
‡ 2004 Finland 425 1 year  1 
Narain et al.
85 1988 USA 396 6 months + 4 
Persson et al.
86 2002 Sweden 83 1 year  1 
Pilotto et al.
87 2008 Italy 857 1 year  5 
Pitkala et al.
88
‡ 2005 Finland 425 1 year  1 
Van Doorn et al.
89
† 2001 USA 524 1 year  1 
Walter et al.
90
* 2001 USA 1495 1 year  5 
*†‡Duplicate study populations were used for these pairs of studies in their respective analyses; Walter et al. 
and Desai et al. were selected for analysis because they evaluated a greater number of domains, and Pitkala et 





All health-related characteristics associated with short-term mortality in one or 
more studies are listed in Table 9.  We classified the characteristics into seven domains:  
cognitive function, disease diagnosis, physical function, laboratory values, nutrition, 
pressure sores, and shortness of breath.  Characteristics with ambiguous classification 
were placed into domains on a case-by-case basis (e.g., albumin was placed under 
nutrition, and delirium under cognitive function).  Since laboratory values were available 
in studies involving hospitalized patients but not in those involving nursing home 
residents, and reports of shortness of breath were only available in the latter, each article 
category contained six domains rather than seven. 
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Table 9.  Patient health-related characteristics associated with short-term mortality 
in at least one study 
 
General nursing home residents
Cognitive function 
Ability to understand or be 
understood 
Change in cognitive status 
CPS 
Decision-making ability 
Decline in cognitive function 
Delirium/delirium symptoms 
Dementia 
Long-term memory impairment 







Congestive heart failure 
Cardiovascular diseases 
Depression 
Disease diagnosis (cont’d) 
Detectable TNF levels 
Diabetes mellitus 
Fever 
Physical health rating 









Bed rail use 
Bedfast all or most of time 
Bowel incontinence 
Decline in ADLs 
Hearing problem 
Not awake most of day 





>25% of food uneaten 
BMI 
Chewing problem 








Shortness of breath 
 
 
Nursing home residents with advanced dementia
Cognitive function 
Absence of Alzheimer's disease 
Cognitive deterioration 
CPS 






















Peripheral vascular disease 




Unstable medical condition 









Not awake most of day 
 
Nutrition 
<25% of food eaten 
BMI 
Chewing or swallowing problem 





Shortness of breath 
 
ADLs=Activities of Daily Living; BMI=Body Mass Index; COPD=Chronic Obstructive Pulmonary Disease; 
CPS=Cognitive Performance Scale; MNA=Mini-Nutritional Assessment; RTI=Respiratory Tract Infection.
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Table 9 (continued).  Patient health-related characteristics associated with short-
term mortality in at least one study 
 
Hospitalized patients with in-hospital mortality 
 
Cognitive function  
Cognitive function score 
CPS 
Delirium (DSM-IV, unspecified) 
Dementia (DSM-IV, Carmel 
Hospital scale) 




Moderate to Severe Dementia 
Short Portable MSQ 
 
Disease diagnosis 
4 or more diagnoses 
APS 
Admission for new problem & 
exacerbated old problem 
Age-comorbidity index 












Index of Coexisting Disease 






Number of additional diagnoses 






ADLs on admission 
Barthel index on admission 
Instrumental ADLs 
Katz scores 
Preadmission ADL impairment 
Red Cross Hospital FDS 


















Albumin <3.5, <3, and <2.8 
BMI 











Table 9 (continued).  Patient health-related characteristics associated with short-term 
mortality in at least one study 
 
Hospitalized patients with mortality up to one year
Cognitive function 
Delirium (DSM-IV, ICD-10) or 
duration of delirium 
Dementia 
MSQ 
Short Portable MSQ 
 
Disease diagnosis 
Acute or chronic renal failure 
APS 




Congestive heart failure 
COPD 
Depression 
History of myocardial infarction 
High risk diagnosis group 
Lymphoma/leukemia 
 
Disease diagnosis (cont’d) 
Malignancy 
Metastatic cancer 







ADLs on admission, during stay, 
or at discharge 




New self-care ADL disability 


















Presence of pressure sores 






ADLs=Activities of Daily Living; APS=Acute Physiology Score; BMI=Body Mass Index; BUN=Blood Urea Nitrogen; 
CCI=Charlson Comorbidity Index; CIRS=Cumulative Illness Rating Scale ; CPS=Cognitive Performance Scale; 
CRP=C-Reactive Protein; FDS=Functional Disability Scale; GDS=Geriatric Depression Scale; MMSE=Mini-Mental 
State Examination; MNA=Mini Nutritional Assessment; MPI=Multidimensional Prognostic Index; MSQ=Mental 
Status Questionnaire; MUST=Malnutrition Universal Screening Tool; PVD=Peripheral vascular disease; 
SGA=Subjective Global Assessment. 
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Frequency of association of characteristics with mortality across studies in bivariate 
and multivariable analyses 
  The 48 studies that met inclusion criteria reported on data from 41 unique 
populations, so seven studies were excluded from the analysis steps (Table 8).  Health-
related characteristics selected according to the criteria described in the methods section, 
and their association with mortality in bivariate and multivariable analysis, are shown in 
Table 10.  Many characteristics that were associated with mortality in bivariate analysis 
failed to retain significance in multivariable analysis. 
General nursing home residents 
Poorer physical function, poorer nutrition, and shortness of breath were 
significant in 100% of bivariate and multivariable analyses.  Poorer cognitive function 
and the presence of pressure sores were associated with mortality in 100% of bivariate 
analyses but were not significant in any multivariable analyses.  Disease diagnosis was 
associated with mortality in 89% of bivariate analyses and in 56% of multivariable 
analyses. 
Nursing home residents with advanced dementia 
All health-related characteristics were associated with mortality in all bivariate 
analyses.  Shortness of breath was significantly associated with mortality in both 
multivariable analyses.  Poorer physical function, pressure sores, and poorer nutrition 
were significantly associated with mortality in 64%, 50%, and 44% of multivariable 
analyses, respectively.  Disease diagnosis was significantly associated with mortality in 




Hospitalized patients:  in-hospital mortality 
Pressure sores were significantly associated with mortality in the only study that 
examined it in both bivariate and multivariable analysis.  Poorer cognitive function, 
poorer physical function, and poorer nutrition were significantly associated with 
mortality in 100%, 88%, and 88% of bivariate analyses, respectively, and in 64%, 57%, 
and 45% of multivariable analyses, respectively.  Disease diagnosis and poorer laboratory 
values were significantly associated with mortality in 74% and 75% of bivariate analyses, 
respectively, and in 36% and 21% of multivariable analyses, respectively. 
Hospitalized patients: mortality up to one year following admission 
Poorer nutrition and the presence of pressure sores were significantly associated 
with mortality in 100% of bivariate analyses and in 86% and 50% of multivariable 
analyses, respectively.  Poorer physical function was significantly associated with 
mortality in 87% of bivariate analyses and 67% of multivariable analyses.  Poorer 
cognitive function, disease diagnosis, and poorer laboratory values were significantly 
associated with mortality in 69%, 73%, and 50% of bivariate analyses, respectively, and 
in 54%, 35%, and 50% of multivariable analyses, respectively. 
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Table 10. Selected health-related patient characteristics and their frequency of 
association with mortality across studies in bivariate and multivariable analyses 
 








Cognitive function    
All cognitive measures 9/9 (100%) 0/9 (0%)  
CPS 1/1 (100%) 0/1 (0%)  
Delirium/delirium symptoms 1/1 (100%) 0/1 (0%)  
Dementia diagnosis 3/3 (100%) 0/3 (0%)  
Short-term memory problem 1/1 (100%) 0/1 (0%)  
    
Disease diagnosis    
All disease diagnoses 17/19 (89%) 9/16 (56%)  
Anemia 2/2 (100%) 0/2 (0%)  
Cancer 2/3 (67%) 1/3 (33%)  
Congestive heart failure 2/2 (100%) 2/2 (100%)  
Diabetes 2/2 (100%) 1/2 (50%)  
Renal failure 0/0 (0%) 0/0 (0%)  
Unstable condition 2/2 (100%) 1/2 (50%)  
    
Physical function    
ADLs  3/3 (100%) 3/3 (100%)  
    
Nutrition    
All nutritional measures 8/8 (100%) 6/6 (100%)  
>25% food uneaten 1/1 (100%) 1/1 (100%)  
BMI 3/3 (100%) 2/2 (100%)  
Swallowing problem 1/1 (100%) 1/1 (100%)  
Weight loss 2/2 (100%) 2/2 (100%)  
    
Pressure sores 2/2 (100%) 0/2 (0%)  
    
Shortness of breath 2/2 (100%) 2/2 (100%)  
    
 
ADLs=Activities of Daily Living; BMI=Body Mass Index; CPS=Cognitive Performance Scale 
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Table 10 (continued). Selected health-related patient characteristics and their 
frequency of association with mortality across studies in bivariate and multivariable 
analyses 






Cognitive function   
All cognitive measures 5/5 (100%) 0/5 (0%) 
Absence of Alzheimer's 1/1 (100%) 0/1 (0%) 
CPS 1/1 (100%) 0/1 (0%) 
Decline in cognitive function 1/1 (100%) 0/1 (0%) 
   
Disease diagnosis   
All disease diagnoses 33/33 (100%) 5/33 (15%) 
Anemia 1/1 (100%) 0/1 (0%) 
Cancer 2/2 (100%) 1/2 (50%) 
Congestive heart failure 2/2 (100%) 2/2 (100%) 
Dehydration 1/1 (100%) 0/1 (0%) 
Diabetes 2/2 (100%) 0/2 (0%) 
Renal failure 1/1 (100%) 0/1 (0%) 
Unstable condition 1/1 (100%) 1/1 (100%) 
   
Physical function   
All functional measures 11/11 (100%) 7/11 (64%) 
ADLs 2/2 (100%) 2/2 (100%) 
ADL decline 1/1 (100%) 0/1 (0%) 
Aspirations 2/2 (100%) 0/2 (0%) 
Bowel incontinence 2/2 (100%) 2/2 (100%) 
Bedfast 2/2 (100%) 2/2 (100%) 
Not awake most of day 2/2 (100%) 1/2 (50%) 
   
Nutrition   
All nutritional measures 9/9 (100%) 4/9 (44%) 
<25% food eaten 1/1 (100%) 1/1 (100%) 
BMI 2/2 (100%) 1/2 (50%) 
Swallowing problem 2/2 (100%) 0/2 (0%) 
Weight loss 2/2 (100%) 1/2 (50%) 
   
Pressure sores 2/2 (100%) 1/2 (50%) 
   
Shortness of breath 2/2 (100%) 2/2 (100%) 
   
 
ADLs=Activities of Daily Living; BMI=Body Mass Index; CPS=Cognitive Performance Scale 
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Table 10 (continued). Selected health-related patient characteristics and their 
frequency of association with mortality across studies in bivariate and multivariable 
analyses 








Cognitive function    
All cognitive measures 15/15 (100%) 7/11 (64%)  
CPS 0/0 (0%) 1/1 (100%)  
Delirium 3/3 (100%) 2/3 (67%)  
Dementia diagnosis 1/1 (100%) 1/1 (100%)  
MMSE 4/4 (100%) 3/4 (75%)  
MSQ 1/1 (100%) 0/1 (0%)  
    
Disease diagnosis    
All disease diagnoses 35/47 (74%) 17/47 (36%)  
Cancer 2/3 (67%) 2/3 (67%)  
CCI 4/4 (100%) 0/4 (0%)  
GIC 2/2 (100%) 2/2 (100%)  
    
Physical function    
All functional measures 14/16 (88%) 8/14 (57%)  
ADLs 6/6 (100%) 4/5 (80%)  
Barthel index 2/2 (100%) 1/2 (50%)  
Upper extremity function 1/1 (100%) 1/1 (100%)  
    
Laboratory values    
All laboratory values 15/20 (75%) 4/19 (21%)  
BUN 1/1 (100%) 0/1 (0%)  
Creatinine 2/2 (100%) 1/2 (50%)  
Hematocrit 0/0 (0%) 0/0 (0%)  
Hemoglobin 1/2 (50%) 0/2 (0%)  
Lymphocyte count 2/3 (67%) 1/3 (33%)  
Sodium 2/2 (100%) 1/2 (50%)  
    
Nutrition    
All nutritional measures 15/17 (88%) 5/11 (45%)  
Albumin  7/7 (100%) 4/6 (67%)  
BMI 1/2 (50%) 0/1 (0%)  
MNA 1/1 (100%) 0/0 (0%)  
    
Pressure sores 1/1 (100%) 1/1 (100%)  
    
 
ADLs=Activities of Daily Living; BMI=Body Mass Index; BUN=Blood urea nitrogen; CCI=Charlson Comorbidity 
Index; CPS=Cognitive Performance Scale; GIC=Geriatrics Index of Comorbidity; MMSE=Mini-Mental State 
Examination; MNA=Mini-Nutritional Assessment; MSQ=Mental Status Questionnaire
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Table 10 (continued). Selected health-related patient characteristics and their 
frequency of association with mortality across studies in bivariate and multivariable 
analyses 







Cognitive function   
All cognitive measures 9/13 (69%) 7/13 (54%) 
CPS 0/0 (0%) 0/0 (0%) 
Delirium 4/6 (67%) 4/6 (67%) 
Dementia diagnosis 3/4 (75% 1/4 (25%) 
MMSE 0/0 (0%) 0/0 (0%) 
MSQ 1/1 (100%) 1/1 (100%) 
   
Disease diagnosis   
All disease diagnoses 29/40 (73%) 14/40 (35%) 
Cancer 3/3 (100%) 3/3 (100%) 
CCI 3/3 (100%) 2/3 (67%) 
Congestive heart failure 2/2 (100%) 2/2 (100%) 
GIC 0/0 (0%) 0/0 (0%) 
   
Physical function   
All functional measures 13/15 (87%) 10/15 (67%) 
ADLs 4/4 (100%) 4/4 (100%) 
Barthel index 3/3 (100%) 2/3 (67%) 
Katz score 2/2 (100%) 2/2 (100%) 
Upper extremity function 0/0 (0%) 0/0 (0%) 
   
Laboratory values   
All laboratory values 4/8 (50%) 4/8 (50%) 
BUN 1/1 (100%) 1/1 (100%) 
Creatinine 2/3 (67%) 2/3 (67%) 
Hematocrit 1/1 (100%) 1/1 (100%) 
Hemoglobin 0/1 (0%) 0/1 (0%) 
Lymphocyte count 0/0 (0%) 0/0 (0%) 
Sodium 0/1 (0%) 0/1 (0%) 
   
Nutrition   
All nutritional measures 10/10 (100%) 6/7 (86%) 
Albumin  2/2 (100%) 2/2 (100%) 
BMI 1/1 (100%) 1/1 (100%) 
MNA or Short MNA 4/4 (100%) 2/2 (100%) 
   
Pressure sores 2/2 (100%) 1/2 (50%) 
   
ADLs=Activities of Daily Living; BMI=Body Mass Index; BUN=Blood urea nitrogen; CCI=Charlson Comorbidity 
Index; CPS=Cognitive Performance Scale; GIC=Geriatrics Index of Comorbidity; MMSE=Mini-Mental State 




Relative strength of association of domains with mortality across individual studies 
in multivariable analysis 
  The relative strength of association of each domain with mortality is summarized 
in Table 11.  For each article category, domains that had ≥50% relative strength (Panel 
A) and ≥75% relative strength (Panel B) were identified, as were those achieving the 
same in high quality articles alone (“relative strength” defined as the number of instances 
a given domain outranked any other domain divided by the total number of instances in 
which the given domain was ranked against other domains, multiplied by 100%). 
 General nursing home residents 
 Among all articles regardless of quality, measures of physical function, nutrition, 
and shortness of breath had ≥75% relative strength, while disease diagnosis had ≥50% 
relative strength.  Among high quality articles only, nutritional measures and shortness of 
breath had ≥75% relative strength, while disease diagnosis had ≥50% relative strength. 
 Nursing home residents with advanced dementia 
 In both the analysis of all articles and the analysis high quality articles only, 
physical function and shortness of breath had ≥ 75% relative strength, and no other 
domain had even as much as ≥50% relative strength. 
 Hospitalized patients:  in-hospital mortality 
 Among all articles regardless of quality, nutrition and pressure sores were the only 
domains to have ≥75% relative strength, whereas disease diagnosis had ≥50% relative 
strength.  Among high quality articles only, pressure sores solely had ≥75% relative 




 Hospitalized patients:  mortality up to one year 
Disease diagnosis, physical function, and nutrition all had ≥75% relative strength 
among all articles regardless of quality.  Among high quality articles only, physical 
function and nutrition had ≥75% relative strength. 
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Table 11.  Domains most strongly associated with short-term mortality in 




























          †   
hospital: 
mortality 
up to one 
year 
     †   †   
*All shaded boxes represent ≥50% relative strength (i.e., domains that outranked the other domains in ≥50% of instances that they 
were compared in multivariable analysis); darker shadings represent that this value was maintained in a separate analysis involving 
high quality articles only. 
†These domains were less commonly examined in articles containing multivariable analysis, so their respective measures of relative 





























          †   
hospital: 
mortality 
up to one 
year 
     † § †   
‡All shaded boxes represent ≥75% relative strength in head-to-head comparisons with other domains; darker shadings represent that 
this value was maintained in a separate analysis involving high quality articles only. 
†These domains were less commonly examined in articles containing multivariable analysis, so their respective measures of relative 
strength may be more subject to chance (see methods). 




 This systematic review of the literature identified numerous health-related 
characteristics of hospitalized patients and nursing home residents significantly 
associated with short-term mortality.  Despite the large number of individual 
characteristics, we were able to group them into a smaller number of clinically 
meaningful domains:  cognitive function, disease diagnosis, physical function, laboratory 
values, nutrition, pressure sores, and shortness of breath.  When we synthesized the 
results by calculating the relative strengths of domains across studies, based on 
performance compared to other domains in multivariable analysis within each study, the 
emerging patterns identified the domains of health that appear to be most important for 
prognostication.  Among general nursing home residents, measures of nutrition and 
shortness of breath were the most important, while disease diagnosis and physical 
function were important to a lesser degree.  Among nursing home residents with 
advanced dementia, physical function and shortness of breath were the most important.  
In the hospitalized elderly, disease diagnosis, nutrition, and pressure sores were the most 
important for in-hospital mortality; on the other hand, for mortality up to one year 
following admission, physical function and nutrition were the most important domains, 
while disease diagnosis had a lesser importance. 
A Domain-Based Approach to Prognostication  
Although the literature describes a large number of individual health-related 
characteristics associated with short-term mortality in the elderly, our review identifies a 
few domains of patient health that are most strongly and consistently associated with 
mortality across populations of hospitalized patients and nursing home residents.  One 
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possible explanation for this consistency is that characteristics within the most important 
domains may be summary measures of a patient’s health that cut across individual 
disease diagnoses and other domains as well.  It has been suggested that a person’s 
functional status may incorporate aspects of disease burden, cognitive status, and 
nutritional status.
111-113
  Nutritional deficits have been thought to both influence and be 
influenced by disease burden and functional status.
114,115
  Dyspnea, commonly a marker 
of cardiac and respiratory disorders, may also induce a high degree of disability.
116,117
  In 
this way, it would seem that these domains are interrelated and broadly reflect a patient’s 
state of health.  As risk factors for mortality, they may reflect physiologic reserve in the 
face of disease burden and other deficits.  In the context of medical decisions for elderly 
patients approaching the end of life, our findings are in keeping with prior arguments that 
an emphasis on disease to the exclusion of other aspects of patient health may result in 
inaccurate assessments, overtreatments, and mistreatments.
118
 
The domains identified in this review as most important can be easily evaluated in 
any clinical setting and do not necessarily involve calculations or specific laboratory 
measurements (nutritional measures include not only albumin, but also BMI, swallowing 
problems, and weight loss).  Although a typical geriatric assessment would provide 
information about these domains,
119
 the substantial lack of physicians’ evaluation of 
functional and nutritional status has been shown in studies involving elderly patients in 
both the primary care setting
120
 and hospital setting.
121
  Our findings argue for the utility 




Rather than aiming for precise prognostic estimates, physicians could use these 
measurements to easily recognize patients for whom an increased risk for mortality might 
warrant a re-evaluation of the approach to care.  Those patients at increased risk would be 
defined by the presence of impairments in one or more of the most important domains of 
health, which effectively serve as markers of vulnerability.  The recognition of increased 
risk for a particular patient may, for example, prompt physicians to engage in advance 
care planning, to discuss hospice as a potential future option in end-of-life care, to 
evaluate their willingness to undergo major or minor therapies, or simply to exercise 
more caution in recommending burdensome treatments or marginally beneficial health 
screening.  Other potential topics for discussion include aspects of life choices, such as 
financial planning and housing arrangements.
59
 Notably, this altered approach on the part 
of the physician would not necessarily require frank discussions about prognosis with 
patients. 
As an additional possibility, physicians might use knowledge of the most 
important domains of health to frame discussions about prognosis with patients and 
families.  A discussion framed around domains of health may enable patients and families 
to appreciate the patient’s health in a broader context rather than focusing on a specific 
diagnosis with a potentially uncertain prognostic course.  Changes in these domains may 
also be readily apparent to patients and families, whereas disease progression may not be 
apparent without laboratory testing or imaging.  Such discussions might aid patients in 
their transition from being seriously ill to dying.
36
 
This proposed alternative approach to prognostication addresses concerns 
physicians have expressed that they are insufficiently prepared to prognosticate or find it 
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difficult, and that patients expect too much certainty in prognostication and might judge 
them adversely if the prognosis is inaccurate.
56
  A domain-based method of identifying 
persons at increased mortality risk would be simple for physicians to use because it 
avoids complex risk calculations composed of various specific measurements that 
physicians are unlikely to utilize, and it applies to elderly individuals regardless of 
primary disease diagnosis.  Additionally, its inability to generate specific time estimates 
avoids both the problem of the inaccuracy of mortality risk calculators and the potential 
for patients to overestimate the accuracy of prognostic calculations.  Finally, it parallels 
recent research suggesting an altered approach to hospice eligibility criteria that involves 
broader patient characteristics, such as decline in functional status, quality of life, and 
burden of symptoms.
30
  In order for such an approach to be applied to something so 
specific as hospice eligibility, guidelines involving broader patient characteristics would 
need to be made, and significantly more research would most likely need to be performed 
to build a foundation for it. 
Considering the Potential Reversibility of Domain Deficits 
Identifying abnormalities in the domains of health most strongly associated with 
mortality introduces the inherent challenge of deciding whether or not intervention is 
likely to benefit the patient, although admittedly our review does not demonstrate a 
causal relationship between any domain and mortality.  On the one hand, if a patient has 
an accumulating burden of these factors, interventions would seem less likely to affect 
the prognosis and may have considerable adverse consequences.  Nonetheless, studies 
have shown that some of these factors can be individually addressed with success, 
suggesting that for certain persons, these factors could be reasonable targets for 
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intervention.  Several randomized control trials have shown that interventions can prevent 
physical functional decline in elderly persons both in the hospital and community.
122-124
 
Pressure sores can be effectively treated, and early prevention measures are important in 
reducing their occurrence.
125,126
 A Cochrane review indicates that protein and energy 
supplementation may reduce mortality and the risk of complications.
127
  
The challenge for future research, then, is to determine for individual patients 
whether interventions might improve their prognosis.  Greater insight into the interplay 
among the domains associated with mortality would likely aid in this endeavor.  
Mapping, which seeks to identify the various routes through which elements can precede 
or contribute to other elements, is a potential way of achieving this.  Another possibility 
is to examine a large cohort of elderly patients and assign to each domain a percent 
contribution to mortality.
128
  Some of the interventional studies previously mentioned that 
sought to improve patient outcomes could be used to conjecture about the likelihood of 
any individual intervention having a positive effect on mortality for a patient.  Ultimately, 
the most definitive way to identify patients who would benefit from a multi-component 
intervention is to design a randomized controlled trial and differentiate elderly sub-
populations according to various outcome measures. 
Limitations 
One limitation to our systematic review is the heterogeneity of study cohorts.  
While this issue precluded a meta-analysis, we were still able to synthesize the data in a 
meaningful way by defining strict inclusion criteria regarding study populations.  
Specifically, we did not include studies whose exclusion criteria eliminated patients with 
characteristics potentially associated with mortality. Additionally, while our newly 
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developed method of calculating relative strength of association of domains with short-
term mortality is a helpful way of synthesizing cohort study data, there is a risk of 
oversimplification in categorizing different characteristics under the heading of one 
domain.  Although conclusions about the usefulness of specific health-related 
characteristics cannot be made based on these calculations, conclusions about the relative 
importance of domains are more in keeping with this limitation.  Furthermore, our first 
method of analysis involving the frequency with which individual factors were associated 
with mortality in bivariate and multivariable analyses provides some data comparing 
characteristics within domains. 
Notably, a few seminal studies on mortality risk for hospitalized patients and 
nursing home residents were not appropriate for the systematic review either because the 
study population included non-elderly persons or because the follow-up period was 
longer than our specified limit of 1 year.  The SUPPORT prognostic model was 
developed in a population of adults 18 years or older with severe illness,
43,129
 and to our 
knowledge, the model was never tested in a cohort of elderly patients.  While the HELP 
prognostic model was developed in a cohort of persons 80 years or older, the follow-up 
period was 2 years.
130
  The Charlson comorbidity index, while developed and validated in 
non-elderly populations,
49
 was assessed in several cohort studies included in this 
review.
77,104,105,110
  Finally, the MDS-CHESS scale for nursing home residents had a 3-






 This review identifies several domains of particular importance in their 
association with short-term mortality (defined as mortality within one year or less) in the 
elderly.  These domains, including physical function, nutrition, and shortness of breath, 
were important when compared to other domains in results of multivariable analysis 
across studies.  Our findings argue for the inclusion of these domains in the general 
assessment of the elderly patient, despite evidence in the literature that physicians often 
do not include them in evaluations.  They may be especially of value in easily identifying 
elderly persons whose increased risk for short-term mortality might prompt a re-
evaluation of the approach to care.  The challenge for future research is to identify 






 This thesis approaches the problem of prognostication in medicine with two 
empiric studies that follow a historical introduction.  The introduction traces the shift that 
occurred in medicine from the first medical “tradition” to the second, the resulting 
transformation of the concept of prognosis, and its decline in status in the practice of 
medicine.  Then a prospective cohort study illustrates the substantial limitations of the 
currently accepted approach to prognostication with the specific example of physicians’ 
decisions to discuss hospice with seriously ill elderly patients.  Finally, a systematic 
review identifies the domains of patient health most strongly and consistently associated 
with short-term mortality in the elderly, in an attempt to suggest an approach to 
prognostication that does not seek estimates of life expectancy. 
 As historical writings convincingly attest, prognostication has suffered from a 
tremendous lack of attention and appreciation for more than a century, in the aftermath of 
a scientific revolution that dramatically advanced diagnostics and treatment options but 
shifted attention from diseased individuals to individual diseases.  After a long period of 
virtually no discussion, a movement to improve the science of prognostication through 
quantification has grown, but it has offered disappointing results in terms of limited 
accuracy and lack of influence on physician-patient communication.  The Medicare 
Hospice Benefit requirement serves to reinforce this fallacious approach to 
prognostication.   Because prognostication is now largely limited to quantitative estimates 
of life expectancy, physicians’ inherent uncertainty about prognosis is a barrier to 
communication with patients as they approach the end of life.  Prognostication, long 
proclaimed an essential component in the practice of medicine, now must acknowledge 
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that certainty about life expectancy is not achievable and alter its focus to assess for 
broad elements of health that indicate increased mortality risk.  This is particularly 
important for elderly patients, many of whom have comorbid conditions and may be 
significantly harmed by available treatments, thus making irrelevant the “diagnose-and-
treat” approach to medicine that had originally diminished the need for prognostic skills. 
 The future of prognostication is exciting, but requires a major shift in both clinical 
research and clinical practice.  Unfortunately, the current pursuit of the “perfect” 
prognostic model has great appeal and heavy momentum behind it despite the 
disappointing objective evidence.  Nonetheless, in the era of an aging population with 
ever-increasing complexity, it is hopeful that physicians’ desire to optimally care for their 
patients will eventually restore prognostication to its proper and historical place alongside 
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